News

Furry Tech Boom: 3 Pet Stocks Unleashing the Power of AI

  • Fortune.com recently reported that artificial intelligence (AI) is helping the pet care industry cope with a chronic veterinary shortage. AI use cases could become far more prevalent for pets than humans in the near term due to fewer impediments such as privacy laws.
    05/01/2024

IDEXX (IDXX) Q1 Earnings Surpass Estimates, 2024 View Slashed

  • IDEXX (IDXX) delivers better-than-expected earnings in the first quarter of 2024.
    05/01/2024
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

IDEXX Laboratories, Inc. (IDXX) can buy. Click on Rating Page for detail.

The price of IDEXX Laboratories, Inc. (IDXX) is 480.6 and it was updated on 2024-05-05 07:00:42.

Currently IDEXX Laboratories, Inc. (IDXX) is in overvalued.

News
    
News

Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics

  • While the top- and bottom-line numbers for Idexx (IDXX) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
    Wed, May. 01, 2024

Idexx Laboratories (IDXX) Tops Q1 Earnings Estimates

  • Idexx Laboratories (IDXX) came out with quarterly earnings of $2.81 per share, beating the Zacks Consensus Estimate of $2.68 per share. This compares to earnings of $2.55 per share a year ago.
    Wed, May. 01, 2024

IDEXX Labs cuts 2024 revenue forecast on lagging vet visits, strong dollar

  • IDEXX Laboratories lowered its annual sales forecast after missing quarterly estimates on Wednesday, as the animal diagnostic equipment maker expects a hit from a slowdown in veterinary clinic visits by pet owners and a stronger dollar.
    Wed, May. 01, 2024

Seeking Clues to Idexx (IDXX) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

  • Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Idexx (IDXX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
    Fri, Apr. 26, 2024

What Lies Ahead of IDEXX Laboratories (IDXX) in Q1 Earnings?

  • IDEXX Laboratories' (IDXX) first-quarter 2024 results are likely to reflect the benefits of strong execution against the growth strategy.
    Fri, Apr. 19, 2024
SEC Filings
SEC Filings

IDEXX Laboratories, Inc. (IDXX) - ARS

  • SEC Filings
  • 03/27/2024

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 03/07/2024

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 03/04/2024

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/22/2024

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/20/2024

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/16/2024

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/12/2024

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/09/2024

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/01/2024

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 01/05/2024

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/08/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/06/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/01/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/22/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/16/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/08/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/01/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/08/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/06/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/05/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/31/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/17/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/14/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/08/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/07/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/01/2023

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 07/12/2023

IDEXX Laboratories, Inc. (IDXX) - SD

  • SEC Filings
  • 05/31/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/22/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/19/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/17/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/15/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/11/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/08/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/05/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/02/2023

IDEXX Laboratories, Inc. (IDXX) - ARS

  • SEC Filings
  • 03/31/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/21/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/17/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/16/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/13/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/10/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/01/2023

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/07/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/06/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/05/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/16/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/14/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/09/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/01/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/08/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/06/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/08/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/02/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 06/03/2022

IDEXX Laboratories, Inc. (IDXX) - SD

  • SEC Filings
  • 05/31/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/23/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/13/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/03/2022

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 03/17/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 03/07/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/25/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/22/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/18/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/17/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/16/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/09/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/01/2022

IDEXX Laboratories, Inc. (IDXX) - 5

  • SEC Filings
  • 01/04/2022

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/01/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/15/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/12/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/10/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/02/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 10/13/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/03/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/02/2021

IDEXX Laboratories, Inc. (IDXX) - 4/A

  • SEC Filings
  • 08/31/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/31/2021

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 08/30/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/25/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/17/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/12/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/09/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/05/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/03/2021

IDEXX Laboratories, Inc. (IDXX) - SD

  • SEC Filings
  • 06/01/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 06/01/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/26/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/24/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/20/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/14/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/12/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/04/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 03/01/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/25/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/24/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/22/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/19/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/18/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/17/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/16/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/08/2021

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/03/2021

IDEXX Laboratories, Inc. (IDXX) - 4/A

  • SEC Filings
  • 12/11/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/03/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/02/2020

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 11/20/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/12/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/10/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/09/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/06/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/05/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/04/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/02/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/02/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/31/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/28/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/24/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/21/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/20/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/18/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/07/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/03/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 06/02/2020

IDEXX Laboratories, Inc. (IDXX) - SD

  • SEC Filings
  • 05/29/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/20/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/15/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/13/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/12/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/08/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/28/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/27/2020

IDEXX Laboratories, Inc. (IDXX) - 4/A

  • SEC Filings
  • 02/24/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/24/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/21/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/20/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/19/2020

IDEXX Laboratories, Inc. (IDXX) - 5

  • SEC Filings
  • 02/14/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/07/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/03/2020

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 01/24/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 01/16/2020

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/03/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/02/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/14/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/12/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/06/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/05/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 10/31/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/04/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/20/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/14/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/12/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/09/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/08/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/07/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/01/2019

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 07/18/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 06/04/2019

IDEXX Laboratories, Inc. (IDXX) - SD

  • SEC Filings
  • 05/31/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/15/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/13/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/10/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/07/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/06/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/02/2019

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 03/08/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 03/01/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/27/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/22/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/20/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/19/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/07/2019

IDEXX Laboratories, Inc. (IDXX) - 5

  • SEC Filings
  • 02/05/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/01/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 01/03/2019

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/07/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/29/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/16/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/07/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/01/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/04/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/30/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/23/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/10/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/09/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/07/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/01/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 06/04/2018

IDEXX Laboratories, Inc. (IDXX) - SD

  • SEC Filings
  • 05/31/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/31/2018

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 05/21/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/11/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/02/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 03/02/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/23/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/20/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/16/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/13/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/09/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/07/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/01/2018

IDEXX Laboratories, Inc. (IDXX) - 3/A

  • SEC Filings
  • 01/26/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 01/11/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 01/05/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 01/03/2018

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/07/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/04/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/16/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/07/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/06/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/01/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/06/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/30/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/25/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/16/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/10/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/09/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/04/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 07/31/2017

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 07/17/2017

IDEXX Laboratories, Inc. (IDXX) - 4/A

  • SEC Filings
  • 06/01/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 06/01/2017

IDEXX Laboratories, Inc. (IDXX) - SD

  • SEC Filings
  • 05/30/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/23/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/11/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/08/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/05/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/01/2017

IDEXX Laboratories, Inc. (IDXX) - 4/A

  • SEC Filings
  • 03/06/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 03/06/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 03/02/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/23/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/21/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/16/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/14/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/09/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 01/31/2017

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 01/06/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 01/04/2017

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/07/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/02/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/30/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/28/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/21/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/10/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/09/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 10/31/2016

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 10/21/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/02/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/26/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/16/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/15/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/09/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/05/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/04/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/02/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 06/02/2016

IDEXX Laboratories, Inc. (IDXX) - SD

  • SEC Filings
  • 05/31/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/31/2016

IDEXX Laboratories, Inc. (IDXX) - 4/A

  • SEC Filings
  • 05/17/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/06/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/05/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/03/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/26/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/25/2016

IDEXX Laboratories, Inc. (IDXX) - 5

  • SEC Filings
  • 02/17/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/17/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/11/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/09/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/02/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 01/05/2016

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/08/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/02/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/16/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/13/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/03/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/03/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/02/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/20/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/19/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/12/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/05/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/03/2015

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 07/24/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 06/19/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 06/03/2015

IDEXX Laboratories, Inc. (IDXX) - SD

  • SEC Filings
  • 06/01/2015

IDEXX Laboratories, Inc. (IDXX) - S-8

  • SEC Filings
  • 05/22/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/20/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/18/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/08/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/05/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/04/2015

IDEXX Laboratories, Inc. (IDXX) - ARS

  • SEC Filings
  • 03/25/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 03/11/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 03/06/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/19/2015

IDEXX Laboratories, Inc. (IDXX) - 4/A

  • SEC Filings
  • 02/18/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/18/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/13/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/09/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/05/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/03/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 01/15/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 01/05/2015

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/29/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/09/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/05/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/19/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/17/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/12/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/07/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/06/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/03/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 10/31/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/03/2014

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 09/03/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/14/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/08/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/07/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/05/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/04/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/01/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 07/31/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 06/03/2014

IDEXX Laboratories, Inc. (IDXX) - SD

  • SEC Filings
  • 06/02/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/09/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/02/2014

IDEXX Laboratories, Inc. (IDXX) - ARS

  • SEC Filings
  • 03/25/2014

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 03/14/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/24/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/21/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/19/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/04/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/03/2014

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 01/03/2014

IDEXX Laboratories, Inc. (IDXX) - S-8

  • SEC Filings
  • 12/30/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/16/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/09/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/27/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/25/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/14/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/06/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/04/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/01/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 10/28/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/17/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/09/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/04/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/01/2013

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 07/23/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 06/04/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/28/2013

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 05/20/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/13/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/10/2013

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 05/10/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/02/2013

IDEXX Laboratories, Inc. (IDXX) - ARS

  • SEC Filings
  • 03/27/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 03/19/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 03/07/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/27/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/19/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/15/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/12/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/05/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/04/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/01/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 01/14/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 01/11/2013

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/21/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/20/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/14/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/04/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/28/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/15/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/14/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/13/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/08/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/07/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/05/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/01/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 10/26/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 10/25/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 10/17/2012

IDEXX Laboratories, Inc. (IDXX) - 4/A

  • SEC Filings
  • 10/11/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 10/11/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/18/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/17/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/14/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/12/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/10/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/06/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/05/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/29/2012

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 08/16/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/13/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/10/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/03/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/01/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 07/27/2012

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 07/16/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 06/05/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/11/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/09/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/08/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/04/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/02/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 04/26/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 04/25/2012

IDEXX Laboratories, Inc. (IDXX) - ARS

  • SEC Filings
  • 03/29/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/27/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/16/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/01/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 01/19/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 01/05/2012

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/20/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/05/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 12/01/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/29/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/18/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 11/01/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 10/06/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/08/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 09/06/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/23/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/16/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 08/02/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 07/29/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 07/18/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 06/22/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 06/08/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 06/02/2011

IDEXX Laboratories, Inc. (IDXX) - 3

  • SEC Filings
  • 06/02/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/26/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/04/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 05/02/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 04/29/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 04/28/2011

IDEXX Laboratories, Inc. (IDXX) - ARS

  • SEC Filings
  • 03/25/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 03/04/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/28/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/22/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/18/2011

IDEXX Laboratories, Inc. (IDXX) - 4

  • SEC Filings
  • 02/16/2011
Press Releases
StockPrice Release
More Headlines
News

TMO vs. IDXX: Which Stock Is the Better Value Option?

  • Investors looking for stocks in the Medical - Instruments sector might want to consider either Thermo Fisher Scientific (TMO) or Idexx Laboratories (IDXX). But which of these two stocks offers value investors a better bang for their buck right now?
  • 04/18/2024

New AI Bot Predicts These 7 Stocks Will Mint Millionaires

  • You may have heard about GPT-4 Turbo, Gemini, Llama or X's (formerly Twitter) Grok. However, there is a new contender outside of these Big Tech models in town.
  • 04/12/2024

Idexx Laboratories (IDXX) Beats Stock Market Upswing: What Investors Need to Know

  • Idexx Laboratories (IDXX) concluded the recent trading session at $519.81, signifying a +0.99% move from its prior day's close.
  • 04/09/2024

All You Need to Know About Idexx (IDXX) Rating Upgrade to Buy

  • Idexx (IDXX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
  • 04/09/2024

Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?

  • Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
  • 04/05/2024

Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now

  • The strength of the CAG Diagnostics business buoys optimism for IDEXX (IDXX).
  • 04/02/2024

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

  • WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: Thursday, February 29, 10:50 am – 11:30 am EST – Brian McKeon, Executive Vice President and Chief Financial Officer, and Tina Hunt, PhD, Executive Vice President, Strategy, Sector Development and Global Operations, will participate in a fireside chat at the BofA Securities Animal Health Virtual Summit. Monday, March 4, 11:00 am –.
  • 02/20/2024

IDEXX (IDXX) Unveils Pet Owner Engagement Software Solution

  • IDEXX's (IDXX) Vello software is an intuitive solution designed specifically for practice management software that enables practitioners to interact with pet owners before and after visits.
  • 02/16/2024

Here's Why You Should Retain IDEXX (IDXX) Stock for Now

  • IDEXX Laboratories, Inc. IDXX is likely to grow in the coming quarters, backed by the sustained success of CAG's recurring diagnostic products and services. The company's international business performance is gaining from its expanded global commercial capability.
  • 02/15/2024

IDEXX's (IDXX) Global Growth Continues, Currency Woes Persist

  • A key element of IDEXX's (IDXX) customer engagement strategy is the expansion of its commercial footprint in a disciplined approach.
  • 02/08/2024

IDEXX Laboratories, Inc. (IDXX) Q4 2023 Earnings Call Transcript

  • IDEXX Laboratories, Inc. (IDXX) Q4 2023 Earnings Call Transcript
  • 02/05/2024

IDEXX (IDXX) Q4 Earnings Surpass Estimates, Margins Fall

  • Across testing modalities, IDEXX (IDXX) achieves strong global growth in the fourth quarter.
  • 02/05/2024

Idexx (IDXX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

  • While the top- and bottom-line numbers for Idexx (IDXX) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
  • 02/05/2024

Idexx Laboratories (IDXX) Q4 Earnings and Revenues Top Estimates

  • Idexx Laboratories (IDXX) came out with quarterly earnings of $2.32 per share, beating the Zacks Consensus Estimate of $2.12 per share. This compares to earnings of $2.05 per share a year ago.
  • 02/05/2024

Should You Buy IDEXX Laboratories (IDXX) Ahead of Earnings?

  • IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
  • 02/02/2024

IQV or IDXX: Which Is the Better Value Stock Right Now?

  • Investors interested in stocks from the Medical - Instruments sector have probably already heard of IQVIA Holdings (IQV) and Idexx Laboratories (IDXX). But which of these two companies is the best option for those looking for undervalued stocks?
  • 01/31/2024

Unveiling Idexx (IDXX) Q4 Outlook: Wall Street Estimates for Key Metrics

  • Evaluate the expected performance of Idexx (IDXX) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
  • 01/31/2024

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

  • Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
  • 01/31/2024

Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now

  • Investors continue to be optimistic about IDEXX (IDXX), backed by the strength of the CAG Diagnostics business.
  • 01/31/2024

Why Idexx (IDXX) is Poised to Beat Earnings Estimates Again

  • Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
  • 01/30/2024

IDEXX Laboratories (IDXX) to Post Q4 Earnings: What's in Store?

  • Strength in CAG Diagnostics and Water businesses are likely to have boosted IDEXX Laboratories' (IDXX) revenues in Q4.
  • 01/29/2024

IDEXX (IDXX) Enhances Fecal Dx Antigen Testing Platform

  • IDEXX's (IDXX) Fecal Dx antigen testing detects the most prevalent and clinically relevant intestinal parasites in dogs and cats.
  • 01/15/2024

3 Purrfect Stocks to Buy for the Booming Pet Care Industry

  • The pet care industry went through a massive growth spurt during the pandemic when it seemed everyone had to own a companion pet. This lit a fire under pet care stocks.
  • 01/11/2024

Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now

  • Investors continue to be optimistic about IDEXX (IDXX), backed by the strength of the CAG Diagnostics business.
  • 12/18/2023

ALC or IDXX: Which Is the Better Value Stock Right Now?

  • Investors with an interest in Medical - Instruments stocks have likely encountered both Alcon (ALC) and Idexx Laboratories (IDXX). But which of these two stocks presents investors with the better value opportunity right now?
  • 11/16/2023

IDEXX's (IDXX) Upcoming Launch to Detect Canine Leishmaniosis

  • IDEXX (IDXX) expands the SNAP franchise with a comprehensive solution for detecting canine leishmaniosis.
  • 11/13/2023

Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now

  • Investors continue to be optimistic about IDEXX (IDXX), backed by the strength of the CAG Diagnostics business and momentum in ProCyte One expansion.
  • 11/09/2023

Compared to Estimates, Idexx (IDXX) Q3 Earnings: A Look at Key Metrics

  • Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
  • 11/01/2023

Among the S&P 500, these 20 companies have made the best use of investors' money

  • There is no easy way to select individual stocks. Measures of financial quality can highlight companies that are worth a closer look, but a decision to commit money must also take into consideration both recent developments and a look ahead.
  • 10/25/2023

IDEXX Laboratories (IDXX) to Post Q3 Earnings: What's in Store?

  • IDEXX Laboratories' (IDXX) third-quarter 2023 results are expected to reflect an impressive performance of the CAG segment.
  • 10/23/2023

IART vs. IDXX: Which Stock Is the Better Value Option?

  • Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (IART) and Idexx Laboratories (IDXX). But which of these two stocks offers value investors a better bang for their buck right now?
  • 10/13/2023

3 Stocks Ready to Rocket on These Global Mega Trends

  • Many investors are used to looking for sectors to make bets on. Technology.
  • 09/28/2023

Here's Why You Should Hold on to IDEXX (IDXX) Stock Right Now

  • Investors are optimistic about IDEXX (IDXX) on solid premium instrument placements and upbeat guidance.
  • 09/19/2023

Which Is A Better Pick – Kimberly-Clark Stock Or IDEXX Laboratories?

  • Given its better prospects, we believe that IDEXX Laboratories stock (NASDAQ: IDXX) is a better pick over Kimberly-Clark stock (NYSE: KMB).
  • 09/15/2023

Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now

  • Investors continue to be optimistic about IDEXX (IDXX) due to the CAG business and the company's execution of its growth strategy.
  • 08/18/2023

3 Top Healthcare Stocks to Buy for August

  • Humana delivered better-than-expected second-quarter earnings. Vertex Pharmaceuticals has three potential blockbuster therapies on the way.
  • 08/05/2023

Atlantic Equities Downgrades Idexx Laboratories

  • Fintel reports that on August 2, 2023, Atlantic Equities downgraded their outlook for Idexx Laboratories (NASDAQ:IDXX) from Overweight to Neutral.
  • 08/02/2023

IDEXX Laboratories, Inc. (IDXX) Q2 2023 Earnings Call Transcript

  • IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q2 2023 Earnings Conference Call August 1, 2023 8:30 AM ET Company Participants Jay Mazelsky - President and Chief Executive Officer Brian McKeon - Chief Financial Officer John Ravis - Vice President, Investor Relations Conference Call Participants Nathan Rich - Goldman Sachs Michael Ryskin - Bank of America Ryan Daniels - William Blair John Block - Stifel David Westenberg - Piper Sandler Operator Good morning, and welcome to the IDEXX Laboratories Second Quarter 2023 Earnings Conference Call. As a reminder, today's conference is being recorded.
  • 08/01/2023

IDEXX (IDXX) Q2 Earnings and Revenues Beat Estimates, View Up

  • IDEXX (IDXX) delivers better-than-expected earnings and revenues in the second quarter of 2023, backed by CAG Diagnostics' recurring revenue growth.
  • 08/01/2023

Idexx (IDXX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

  • The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
  • 08/01/2023

Idexx Laboratories (IDXX) Q2 Earnings and Revenues Beat Estimates

  • Idexx Laboratories (IDXX) came out with quarterly earnings of $2.67 per share, beating the Zacks Consensus Estimate of $2.43 per share. This compares to earnings of $1.56 per share a year ago.
  • 08/01/2023

IDEXX Laboratories (IDXX) to Post Q2 Earnings: What's in Store?

  • IDEXX Laboratories' (IDXX) second-quarter 2023 results are expected to reflect an impressive performance in the CAG segment.
  • 07/21/2023

Idexx Laboratories (IDXX) is a Top-Ranked Momentum Stock: Should You Buy?

  • The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
  • 07/14/2023

IDEXX: One Of The Best Compounders On The Market

  • IDEXX Laboratories, a healthcare supplier specializing in veterinary health diagnostics and research, is a potential high-performing compounder due to its wide-moat business model, anti-cyclical customers, strong pricing power, and high free cash flow conversion. Despite not offering dividends, IDEXX has returned nearly 1,000% over the past decade, and its focus on fast-growing veterinary healthcare and aim to increase its installed base of premium instruments could contribute to further revenue expansion.
  • 06/29/2023

IDEXX (IDXX) Stock Up 18.4% YTD: Will the Rally Continue?

  • The continued solid demand for veterinary services and benefits from strong execution poise IDEXX (IDXX) well for future growth.
  • 06/19/2023

IDEXX (IDXX) Launches First Veterinary Diagnostic Test

  • IDEXX's (IDXX) Cystatin B Test can help veterinary professionals to spot kidney damage before it affects kidney function, which may result in better patient outcomes.
  • 06/16/2023

3 Nasdaq Stocks That Have Generated 10x Returns in 10 Years

  • Investing $10,000 into Apple, Nvidia, or Idexx Laboratories a decade ago would have netted you more than $100,000 today. Both Apple and Nvidia have some exciting next-gen growth opportunities to pursue that could ensure their businesses continue to grow in the years ahead.
  • 06/08/2023

Here's Why You Should Invest in IDEXX (IDXX) Right Now

  • Investors continue to be optimistic about IDEXX (IDXX) on the strength of the Companion Animal Group business.
  • 06/06/2023

IDEXX Laboratories to Present at Stifel Conference and Announces 2023 Investor Day

  • WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Stifel Jaws & Paws Conference on Wednesday, May 31, 2023. Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at 1:15 pm (EDT). Individuals can access the live audio webcast of the presentation through a link on the IDEXX website, www.idexx.
  • 05/10/2023

3 Best Stocks to Buy in May and Hold Forever

  • Teladoc looks to transition from a high-flying growth story to a profitable enterprise. Doximity's early profitability and cash generation point to incredible potential ahead.
  • 05/10/2023

IDEXX (IDXX) Q1 Earnings Beat Estimates, Margins Increase

  • Continued solid demand for veterinary services and record global premium instrument placements drive IDEXX's (IDXX) Q1 revenues.
  • 05/02/2023

IDEXX Laboratories, Inc. (IDXX) Q1 2023 Earnings Call Transcript

  • IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q1 2023 Earnings Conference Call May 2, 2023 8:30 AM ET Company Participants Jay Mazelsky - President and Chief Executive Officer Brian McKeon - Executive Vice President, Chief Financial Officer John Ravis - Vice President, Investor Relations Conference Call Participants Nathan Rich - Goldman Sachs Christopher Schott - JPMorgan Jonathan Block - Stifel Michael Ryskin - Bank of America Jack Senft - William Blair Erin Wright - Morgan Stanley David Westenberg - Piper Sandler Operator Good morning, and welcome to the IDEXX Laboratories First Quarter 2023 Earnings Conference Call. As a reminder, today's conference is being recorded.
  • 05/02/2023

Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics

  • The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
  • 05/02/2023

Idexx Laboratories (IDXX) Q1 Earnings and Revenues Beat Estimates

  • Idexx Laboratories (IDXX) came out with quarterly earnings of $2.55 per share, beating the Zacks Consensus Estimate of $2.38 per share. This compares to earnings of $2.27 per share a year ago.
  • 05/02/2023

Why These 2 Vet Med Stocks Are Surging

  • Nearly 87 million households -- over two-thirds of the total -- own at least one pet. Spending on pet healthcare could nearly double by 2030 to $112 billion.
  • 04/28/2023

Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?

  • Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 04/25/2023

7 ESG Stocks to Buy That Analysts Love

  • Stereotypically, the concept of bidding up publicly traded enterprises based on their environmental, social, and governance scores – the so-called ESG stocks – might seem an extremely risky proposition. That's because we have this idea that doing good involves sacrificing capitalistic intent like achieving profitability.
  • 04/25/2023

3 Pet Stocks That Could Purr in 2023 and Beyond

  • Animal-loving investors may be interested in exploring opportunities in the pet industry. While there are altruistic reasons for supporting companies that focus on the well-being of our furry friends, pet stocks have also seen impressive growth over the past decade, which was accelerated by the pandemic.
  • 04/24/2023

IDEXX Laboratories (IDXX) to Post Q1 Earnings: What's in Store?

  • IDEXX Laboratories' (IDXX) first-quarter 2023 results are expected to reflect an impressive performance in the CAG segment despite inflationary impacts.
  • 04/21/2023

ALC vs. IDXX: Which Stock Is the Better Value Option?

  • Investors interested in stocks from the Medical - Instruments sector have probably already heard of Alcon (ALC) and Idexx Laboratories (IDXX). But which of these two stocks offers value investors a better bang for their buck right now?
  • 04/12/2023

Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now

  • Investors are optimistic about IDEXX's (IDXX) strength in the Companion Animal Group business.
  • 04/10/2023

Why Is Idexx (IDXX) Down 6.6% Since Last Earnings Report?

  • Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
  • 03/08/2023

TMO or IDXX: Which Is the Better Value Stock Right Now?

  • TMO vs. IDXX: Which Stock Is the Better Value Option?
  • 03/08/2023

Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now

  • Investors are optimistic about IDEXX's (IDXX) strong global performance.
  • 02/28/2023

IDEXX (IDXX) Global Sales, Instrument Placement Robust

  • IDEXX (IDXX) continues to demonstrate solid growth globally, primarily aided by a gain in CAG and Water businesses.
  • 02/27/2023

IDEXX Laboratories: Excellent Business But Extremely Overpriced

  • IDEXX Laboratories, Inc. is a U.S. healthcare company, that currently leads the veterinary industry developing diagnostics tools to satisfy veterinarians' everyday needs. IDEXX has delivered solid and consistent results that rival those of Google's, Metas', and Microsoft's out there.
  • 02/24/2023

3 Medical Instruments Stocks to Buy Amid Improving Industry Trends

  • The Zacks Medical - Instruments industry is growing on rising demand for digital health. EW, IDXX and HOLX are set to gain the most.
  • 02/23/2023

Are Medical Stocks Lagging IDEXX Laboratories (IDXX) This Year?

  • Here is how Idexx Laboratories (IDXX) and Aeterna Zentaris (AEZS) have performed compared to their sector so far this year.
  • 02/23/2023

TMO vs. IDXX: Which Stock Is the Better Value Option?

  • TMO vs. IDXX: Which Stock Is the Better Value Option?
  • 02/20/2023

2 Top Healthcare Stocks to Buy Right Now

  • One has a breakout drug, the other a nice-sized moat.
  • 02/13/2023

2 Top Stocks I'm Buying Hand Over Fist in February

  • Despite underwhelming earnings reports, these businesses remain great investments in 2023.
  • 02/10/2023

IDEXX Laboratories, Inc. (IDXX) Q4 2022 Earnings Call Transcript

  • IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q4 2022 Results Conference Call February 6, 2023 8:30 AM ET Company Participants Jay Mazelsky - President and Chief Executive Officer Brian McKeon - Chief Financial Officer John Ravis - Vice President, Investor Relations Conference Call Participants Nathan Rich - Goldman Sachs Chris Schott - JPMorgan Erin Wright - Morgan Stanley Michael Ryskin - Bank of America Jon Block - Stifel Ryan Daniels - William Blair Operator Good morning, and welcome to the IDEXX Laboratories Fourth Quarter 2022 Earnings Conference Call. As a reminder, today's conference is being recorded.
  • 02/06/2023

IDEXX (IDXX) Q4 Earnings Beat Estimates, Margins Increases

  • IDEXX's (IDXX) Q4 revenues are driven by continued benefits from expanding the global premium instrument installed base.
  • 02/06/2023

Idexx Laboratories (IDXX) Q4 Earnings and Revenues Beat Estimates

  • Idexx (IDXX) delivered earnings and revenue surprises of 6.77% and 1.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 02/06/2023

SONVY or IDXX: Which Is the Better Value Stock Right Now?

  • SONVY vs. IDXX: Which Stock Is the Better Value Option?
  • 01/31/2023

Top 5 Nasdaq Composite Stocks to Buy Ahead of Q4 Earnings

  • Five Nasdaq Composite companies are set to beat earnings estimates. These are: EXPE, IDXX, SNY, TW and SEDG.
  • 01/31/2023

Nasdaq Off To Its Fastest Start Since 2019 — These Stocks Are Leading The Charge

  • The Nasdaq composite is up 6.44% in 2023, its best start to a new year. These are the big Nasdaq winners, including some megacaps.
  • 01/23/2023

Nasdaq Off To Its Fastest Start Since 2019 — These Stocks Are Leading The Charge

  • The Nasdaq composite is up 6.44% in 2023, its best start to a new year. These are the big Nasdaq winners, including some megacaps.
  • 01/22/2023

Why Idexx (IDXX) Could Beat Earnings Estimates Again

  • Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
  • 01/17/2023

IDEXX (IDXX) Aided by Global Growth, Solid Instrument Placement

  • IDEXX's (IDXX) rapid assay revenue growth is supported by solid volume gains in the United States and benefits from net price increases.
  • 01/17/2023

5 Stocks Powering Nasdaq ETF to Start 2023

  • The rally has been broad-based. And the high beta and high growth sector took charge, with the tech-heavy Nasdaq Composite Index rising 5.1% in the initial two weeks of 2023.
  • 01/13/2023

VolitionRx announces expansion of availability of Nu.Q Vet Cancer Test availability through IDEXX's reference laboratory network

  • VolitionRx Ltd (NYSE-A:VNRX) has announced the availability of its Nu.Q Vet Cancer Test through the IDEXX Laboratories Inc reference laboratory network in the US. The Henderson, Nevada-based multi-national epigenetics company noted that IDEXX is a global leader in pet healthcare innovation and is well-positioned to roll out the IDEXX Nu.Q Canine Cancer Screen worldwide.
  • 01/12/2023

7 Nasdaq Stocks to Buy and Hold Forever

  • After watching the Nasdaq lose roughly a third of its value in 2022, investors might rightly be wary of that particular stock exchange. However, the truth is that there are still plenty of Nasdaq stocks that have created tremendous wealth for long-term investors.
  • 01/08/2023

IDEXX Laboratories to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference

  • WESTBROOK, Maine , Dec. 22, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Thursday, January 5, 2023. Jay Mazelsky, President and Chief Executive Officer will participate in a fireside chat at 1:15 pm ET.
  • 12/22/2022

The 7 Best Stocks to Buy for 2023

  • There are just a couple of weeks left in 2022. I've been tasked with selecting the seven best stocks to buy for 2023.
  • 12/14/2022

IDEXX (IDXX) CAG Sales Growth Strong, Costs Continue to Rise

  • IDEXX's (IDXX) international revenues are primarily aided by gains in CAG and Water businesses.
  • 12/14/2022

Is There More Room For Growth In IDEXX Laboratories Stock?

  • This 137% growth for IDXX stock since late 2018 can primarily be attributed to 1 the company's P/S ratio rising 53% to 11.1x trailing revenues, from 7.3x in 2018, 2.
  • 11/15/2022

IDEXX (IDXX) Q3 Earnings Beat Estimates, 2022 EPS View Down

  • IDEXX's (IDXX) Q3 top-line performance rides on strong CAG Diagnostics recurring revenue growth.
  • 11/01/2022

IDEXX Laboratories, Inc. (IDXX) Q3 2022 Earnings Call Transcript

  • IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q3 2022 Earnings Conference Call November 1, 2022 8:30 AM ET Company Participants Brian McKeon - CFO Jay Mazelsky - CEO Conference Call Participants Chris Schott - JPMorgan Erin Wright - Morgan Stanley Jon Block - Stifel Nathan Rich - Goldman Sachs David Westenberg - Piper Sandler Ryan Daniels - William Blair Elliot Wilbur - Raymond James Operator Good morning, and welcome to the IDEXX Laboratories Third Quarter 2022 Earnings Conference Call. As a reminder, today's conference is being recorded.
  • 11/01/2022

Why IDEXX Stock Popped Today

  • The animal healthcare company beat estimates on the top and bottom lines.
  • 11/01/2022

Idexx Laboratories (IDXX) Beats Q3 Earnings and Revenue Estimates

  • Idexx (IDXX) delivered earnings and revenue surprises of 5.39% and 1.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 11/01/2022

A Quality Checkup On IDEXX Laboratories

  • IDEXX Laboratories is operating in an industry with good tailwinds. Over the last decade, IDEXX Laboratories returned 22% annually, but future returns will likely be much lower.
  • 10/26/2022

7 Nasdaq Stocks to Buy and Hold Forever

  • The Nasdaq is known for high-flying growth stocks, not necessarily buy-and-hold candidates. Electric vehicles, biotechnology, social networking stocks, cloud software companies and the like.
  • 10/13/2022

Don't Miss the Turnaround in These 3 Stocks

  • I'm on the hunt for stocks to buy that are primed for a turnaround in the final quarter of 2022 and into 2023.  But what constitutes a turnaround?
  • 10/04/2022

Should You Buy IDEXX Laboratories Stock At Around $350?

  • IDEXX Laboratories stock (NASDAQ: IDXX) has seen a 48% decline this year, faring far worse than an 18% fall for the broader S&P500 index.
  • 09/08/2022

5 Pet Care Stocks Gurus Love

  • Despite inflationary pressures that are increasing the price of goods across the board, consumers are still pampering their pets when it comes to food.
  • 09/02/2022

Why Is Idexx (IDXX) Down 14.6% Since Last Earnings Report?

  • Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
  • 09/01/2022

IDEXX (IDXX) Suffers From Macro Headwinds, Cost Constraints

  • The strengthening of the rate of exchange for the U.S. dollar relative to other currencies has a negative impact on IDEXX's (IDXX) revenues.
  • 08/18/2022

IDEXX Laboratories: Outstanding Business, But Valuation Is Key

  • IDEXX Laboratories enjoys a dominant market position in the veterinary care ecosystem. It is also establishing itself in adjacencies like livestock and water testing. The company's business has sticky, recurring revenues with strong defensibility during uncertain economic times.
  • 08/15/2022

IDEXX (IDXX) Q2 Earnings Surpass Estimates, 2022 View Down

  • IDEXX's (IDXX) Q2 top-line benefits from strong sales at the CAG and Water businesses.
  • 08/02/2022

IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q2 2022 Results - Earnings Call Transcript

  • IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q2 2022 Earnings Conference Call August 2, 2022 8:30 AM ET Company Participants Brian McKeon - Executive Vice President, Chief Financial Officer & Treasurer Jay Mazelsky - President & Chief Executive Officer Conference Call Participants Michael Ryskin - Bank of America Chris Schott - JPMorgan Erin Wright - Morgan Stanley Jon Block - Stifel Elliot Wilbur - Raymond James Ryan Daniels - William Blair Operator Good morning, and welcome to the IDEXX Laboratories Second Quarter 2022 Earnings Conference Call. As a reminder, today's conference is being recorded.
  • 08/02/2022

Idexx Laboratories (IDXX) Surpasses Q2 Earnings Estimates

  • Idexx (IDXX) delivered earnings and revenue surprises of 1.30% and 0.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 08/02/2022

OCPNY or IDXX: Which Is the Better Value Stock Right Now?

  • OCPNY vs. IDXX: Which Stock Is the Better Value Option?
  • 07/27/2022

The 3 Best Pet Stocks to Buy Now

  • Pets are a big part of the family in America and that trend is only growing. Here are some top pet stocks to help you profit from the trend.
  • 07/04/2022

Why Is Idexx (IDXX) Up 0.3% Since Last Earnings Report?

  • Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
  • 06/03/2022

IDEXX's (IDXX) Soft LPD Sales, Margin Pressure Concern

  • Distributor purchasing dynamics have an impact on IDEXX's (IDXX) CAG segment product sales.
  • 05/25/2022

IDEXX Laboratories: Great Business, But Still Overvalued

  • IDEXX Laboratories offers products and services in the animal companion diagnostics and testing space. The company has an outstanding track record regarding deployment of capital and shareholder returns.
  • 05/25/2022

IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day

  • WESTBROOK, Maine , May 18, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in the Stifel Jaws & Paws Conference on Wednesday, June 1, 2022. Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at 1:50 pm (EDT).
  • 05/18/2022

IDEXX (IDXX) Q1 Earnings Surpass Estimates, Margins Down

  • Strong sales at the CAG and Water businesses drove IDEXX's (IDXX) first-quarter 2022 revenues.
  • 05/04/2022

IDEXX Laboratories, Inc. (IDXX) CEO Jonathan Mazelsky on Q1 2022 Results - Earnings Call Transcript

  • IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q1 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Brian McKeon - CFO, EVP & Treasurer Jonathan Mazelsky - President, CEO & Director Conference Call Participants Christopher Schott - JPMorgan Chase & Co Michael Ryskin - Bank of America Merrill Lynch Erin Wright - Morgan Stanley Jonathan Block - Stifel, Nicolaus & Company Nathan Rich - Goldman Sachs Group Balaji Prasad - Barclays Bank Operator Good morning, and welcome to the IDEXX Laboratories First Quarter 2022 Earnings Conference Call. As a reminder, today's conference is being recorded.
  • 05/04/2022

Idexx Laboratories (IDXX) Q1 Earnings Beat Estimates

  • Idexx (IDXX) delivered earnings and revenue surprises of 0.89% and 0.57%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
  • 05/04/2022

Why ESG Investing Doesn't Actually Work

  • The practice of investing based on environmental, social and governance (ESG) criteria has become increasingly popular over the years. Last year was a banner year for cash inflows to ESG funds, with these funds reaching a record of approximately $330 billion in collective assets under management according to data from Morningstar.
  • 05/03/2022

MedTech Stocks' Q1 Earnings Due on May 4: CRL, IDXX & NUVA

  • MedTech companies' results are likely to reflect a rebound in the base business. Let's see how CRL, IDXX and NUVA fare this time.
  • 05/03/2022

Earnings Preview: Idexx Laboratories (IDXX) Q1 Earnings Expected to Decline

  • Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 04/27/2022

According To Analysts, These 12 Fast-Rising Stocks Are On The Way Up

  • A dozen S&P 500 stocks are up strongly from the market's low this year, including consumer discretionary firms Pool and D.R. Horton plus communications services company Dish Network.
  • 04/14/2022

Wall Street Thinks This Stock Has 50% Upside

  • That prediction might be too conservative.
  • 04/14/2022

IDEXX (IDXX) CAG Sales Gain Traction, FX Headwind Persists

  • IDEXX (IDXX) has been witnessing continued high CAG Diagnostics recurring revenue growth across major regions with solid gains across its key in-clinic platforms.
  • 04/12/2022

IHI: A Standout Performer With Equally Strong Future Growth Prospects

  • IHI: A Standout Performer With Equally Strong Future Growth Prospects
  • 03/05/2022

Riding The Stock Waves: Update On The Medical Devices Sector

  • Riding The Stock Waves: Update On The Medical Devices Sector
  • 02/21/2022

IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

  • WESTBROOK, Maine, Feb. 17, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in two upcoming conferences: Thursday, February 24, 9:55 am EST  – Tina Hunt, PhD, Executive Vice President and General Manager, Point of Care Diagnostics and Worldwide Operations and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the BofA Securities Animal Health Summit. Monday, March 7, 11:00 am EST  – Jay Mazelsky, President and Chief Executive Officer, will present at the 43rd Annual Raymond James Institutional Investors Conference.
  • 02/17/2022

Here's Why You Should Hold on to IDEXX (IDXX) Stock for Now

  • Robust domestic and international performances by the CAG arm are driving IDEXX's (IDXX) fourth-quarter top line.
  • 02/17/2022

2 Stocks With COVID Gains Wall Street Shouldn't Erase

  • These charts show how some pandemic winners will keep delivering for shareholders.
  • 02/09/2022

IDEXX: The Robust Stalwart

  • A stalwart stock, according to legendary investor Peter Lynch, is a large, stable company that still has attractive growth potential.
  • 02/08/2022

IDEXX's (IDXX) CAG Diagnostic Sales Gain, Cost Woe Stays

  • IDEXX (IDXX) witnesses continued high CAG Diagnostics recurring revenue growth across major regions with solid gains across its key in-clinic platforms.
  • 02/08/2022

IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q4 2021 Results - Earnings Call Transcript

  • IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q4 2021 Results - Earnings Call Transcript
  • 02/02/2022

IDEXX Laboratories And Its Real Value

  • IDEXX Laboratories has directly benefitted from the COVID-19 pandemic as diagnostic testing of animals has increased. Share prices and earnings per share have been increasing consistently over the last decade.
  • 02/02/2022

IDEXX (IDXX) Q4 Earnings Beat Estimates, Gross Margin Up

  • Growth in CAG Diagnostics revenues and CAG Diagnostics capital instrument revenues drove IDEXX (IDXX) Q4 revenues.
  • 02/02/2022

Idexx Laboratories (IDXX) Tops Q4 Earnings and Revenue Estimates

  • Idexx (IDXX) delivered earnings and revenue surprises of 13.17% and 2.67%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 02/02/2022

IDEXX (IDXX) Collaborates With PetDx for Canine Cancer Test

  • Following the partnership between IDEXX (IDXX) and PetDx , the test is likely to be available later in January to all veterinary customers of IDXX in the United States and Canada.
  • 01/17/2022

Idexx Laboratories (IDXX) Gains As Market Dips: What You Should Know

  • Idexx Laboratories (IDXX) closed at $661.32 in the latest trading session, marking a +0.86% move from the prior day.
  • 12/30/2021

IDEXX's (IDXX) Organic Growth Robust, LPD Revenues Decline

  • IDEXX's (IDXX) global Reference Lab businesses continue to be robust driven by high same-store volume growth with strong gains across testing categories.
  • 12/28/2021

Idexx Laboratories (IDXX) Outpaces Stock Market Gains: What You Should Know

  • Idexx Laboratories (IDXX) closed at $645.02 in the latest trading session, marking a +0.78% move from the prior day.
  • 12/24/2021

Idexx Laboratories (IDXX) Dips More Than Broader Markets: What You Should Know

  • Idexx Laboratories (IDXX) closed the most recent trading day at $596.35, moving -1.49% from the previous trading session.
  • 12/14/2021

Idexx Laboratories (IDXX) Outpaces Stock Market Gains: What You Should Know

  • Idexx Laboratories (IDXX) closed at $618.55 in the latest trading session, marking a +1.16% move from the prior day.
  • 12/08/2021

Here's Why You Should Retain IDEXX (IDXX) Stock for Now

  • Investors are optimistic about IDEXX's (IDXX) better-than-expected results and continued international growth in the third quarter.
  • 12/06/2021

IDEXX (IDXX) CAG Placement Grows Globally, LPD Disappoints

  • IDEXX' (IDXX) global Reference Lab businesses are robust driven by high same-store volume growth with strong gains across testing categories.
  • 11/09/2021

IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q3 2021 Results - Earnings Call Transcript

  • IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q3 2021 Results - Earnings Call Transcript
  • 11/02/2021

IDEXX (IDXX) Q3 Earnings Beat Estimates, Gross Margin Falls

  • IDEXX's (IDXX) Q3 top line rides on strong sales at the CAG and Water businesses.
  • 11/02/2021

Idexx Laboratories (IDXX) Beats Q3 Earnings and Revenue Estimates

  • Idexx (IDXX) delivered earnings and revenue surprises of 7.98% and 2.16%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 11/02/2021

Medical Products Stock Earnings on Nov 2: IDXX, STE & More

  • With the pandemic raging on, testing, vaccine and therapeutic makers are witnessing huge market adoption of their COVID-related support products in Q3.
  • 11/01/2021

Idexx Laboratories (IDXX) Crossed Above the 50-Day Moving Average: What That Means for Investors

  • Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
  • 11/01/2021

4 Medical Products Stocks Poised to Beat This Earnings Season

  • Amid concerns surrounding growing COVID-19 cases affecting the medical products companies' legacy business, we are optimistic about IDXX, HSIC, CGC and PODD's results this time around.
  • 10/28/2021

Idexx Laboratories (IDXX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

  • Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 10/26/2021

IDEXX Laboratories to Release 2021 Third Quarter Financial Results

  • WESTBROOK, Maine, Oct. 8, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2021 third quarter financial results for Tuesday, November 2, 2021 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m.
  • 10/08/2021

3 Stocks Growing Free Cash Flow Fast

  • If you are screening the market for investment opportunities among U.S.-listed equities, you may want to consider the stocks listed below, as they have seen their free cash flow increase notably over recent years. As a result, these businesses should be flexible enough to continue to support the development of projects and return cash to shareholders.
  • 10/07/2021

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

  • Is (IDXX) Outperforming Other Medical Stocks This Year?
  • 09/28/2021

Why Are the Nasdaq's Top Growth Stocks Freaking Out Monday?

  • None of it has anything to do with business fundamentals.
  • 09/27/2021

IDEXX (IDXX) CAG Placement Grows Globally Amid Cost Woes

  • IDEXX's (IDXX) global reference lab revenues are growing organically, reflecting growth in the United States and the international markets.
  • 09/27/2021

Here's Why You Should Add IDEXX (IDXX) to Your Portfolio Now

  • Investors are optimistic about IDEXX (IDXX) on strong growth in CAG business and solid global performance.
  • 09/20/2021

Is IDEXX Laboratories (IDXX) Stock Outpacing Its Medical Peers This Year?

  • Is (IDXX) Outperforming Other Medical Stocks This Year?
  • 09/11/2021

4 MedTechs to Gain in 2H21 Beating the Delta Variant-Led Dip

  • Investors can choose to invest in MedTech stocks like VREX, OMCL, STAA, and IDXX that have shown tremendous promise amid the pandemic.
  • 08/31/2021

Nasdaq Clear Winner In Mixed Market; Apple, PYPL, And Idexx In Focus $AAPL $PYPL $IDXX

  • Nasdaq clear winner in mixed market; Apple, PYPL, and Idexx in focus. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.
  • 08/30/2021

Nasdaq Clear Winner In Mixed Market; Apple, PYPL, And Idexx In Focus $AAPL $PYPL $IDXX

  • Nasdaq clear winner in mixed market; Apple, PYPL, and Idexx in focus. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.
  • 08/30/2021

Idexx (IDXX) is an Incredible Growth Stock: 3 Reasons Why

  • Idexx (IDXX) possesses solid growth attributes, which could help it handily outperform the market.
  • 08/30/2021

Stocks Rally On Fed Chief Powell; CrowdStrike Keeps Running; Idexx Labs, Shopify Set Up

  • Stocks rally on Fed chief Powell; CrowdStrike keeps running; Idexx Labs, Shopify set up. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.
  • 08/27/2021

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

  • Is (IDXX) Outperforming Other Medical Stocks This Year?
  • 08/24/2021

Here's Why You Should Add IDEXX (IDXX) to Your Portfolio Now

  • Investors are optimistic about IDEXX (IDXX) on strong growth in CAG business and raised 2021 outlook.
  • 08/20/2021

3 Smartest Healthcare Stocks to Buy With $1,000 Right Now

  • It doesn't take a brainiac to balance risk and reward.
  • 08/18/2021

Time to Focus on IDEXX Laboratories (IDXX) for Strong Earnings Growth Potential

  • If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider IDEXX Laboratories (IDXX).
  • 08/17/2021

3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)

  • Idexx (IDXX) possesses solid growth attributes, which could help it handily outperform the market.
  • 08/11/2021

IDEXX Laboratories to Host Virtual Investor Day

  • WESTBROOK, Maine, Aug. 9, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will host its 2021 virtual Investor Day on Thursday, August 12, 2021 from 10:00 am to approximately 12:30 pm EDT. The virtual investor day will include executive presentations followed by a question and answer session.
  • 08/09/2021

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

  • Is (IDXX) Outperforming Other Medical Stocks This Year?
  • 08/05/2021

3 Medical Instruments Stocks Countering Industry Headwinds

  • The Zacks Medical - Instruments industry is growing on base business recovery. ISRG, IDXX and ALC are set to gain the most.
  • 08/04/2021

IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q2 2021 Results - Earnings Call Transcript

  • IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q2 2021 Results - Earnings Call Transcript
  • 07/30/2021

IDEXX (IDXX) Q2 Earnings Beat Estimates, 2021 Guidance Up

  • Strength in CAG Diagnostics and Water businesses drove IDEXX's (IDXX) second-quarter revenues.
  • 07/30/2021

Idexx Laboratories (IDXX) Q2 Earnings and Revenues Top Estimates

  • Idexx (IDXX) delivered earnings and revenue surprises of 16.42% and 5.72%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 07/30/2021

IDEXX Laboratories Announces Second Quarter Results

  • WESTBROOK, Maine, July 30, 2021 /PRNewswire/ -- Achieves reported revenue growth of 30% and organic revenue growth of 25%, driven by CAG Diagnostics recurring revenue growth of 30% as reported and 26% organic Delivers EPS of $2.34, representing 36% growth as reported and 33% on a comparable basis Increases 2021 revenue guidance to $3,170 million - $3,205 million, reflecting higher expectations for reported growth of 17% - 18.5% and organic growth of 14.5% - 16%, supported by projected CAG Diagnostics recurring revenue growth of 18% - 19.5% as reported and 16% - 17.5% organic Raises 2021 EPS outlook to $8.20 - $8.36, reflecting an increase of 1% - 1.5% in the organic revenue growth outlook and expectations for higher operating margins of 28.6% - 29.1% IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced second quarter results, as well as an update on U.S. companion animal diagnostics sector trends. Second Quarter Results The Company reports revenues of $826 million for the second quarter of 2021, an increase of 30% as reported and 25% organically.
  • 07/30/2021

Why IDEXX Laboratories (IDXX) Might Surprise This Earnings Season

  • IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
  • 07/29/2021

What's in Store for IDEXX Laboratories (IDXX) in Q2 Earnings?

  • IDEXX's (IDXX) fiscal second-quarter top line is expected to have benefited from strength in CAG and LPD businesses.
  • 07/27/2021

IDEXX Laboratories: This Growth Name Is On Fire

  • IDEXX Laboratories has seen impressive revenue and margin growth in recent years. It's expanding its cloud presence, and is benefiting from the current pet-friendly environment.
  • 07/25/2021

Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?

  • Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 07/23/2021

3 Surprising Stocks That Have Crushed the Market so Far This Year

  • They're not the growth stocks you're probably used to being huge winners.
  • 07/22/2021

Can Idexx (IDXX) Keep the Earnings Surprise Streak Alive?

  • Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
  • 07/20/2021

Here's How Much a $1000 Investment in Idexx Laboratories Made 10 Years Ago Would Be Worth Today

  • Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
  • 07/19/2021

The InvestorPlace Q&A: Embrace Investing in Momentum With the ProShares QQQA ETF

  • Investors should consider the QQQA exchange-traded fund in order to diversify their portfolio with a solid investing philosophy. The post The InvestorPlace Q&A: Embrace Investing in Momentum With the ProShares QQQA ETF appeared first on InvestorPlace.
  • 07/07/2021

Why Idexx Laboratories Gained 13% in June

  • The veterinary products company gained after an acquisition.
  • 07/06/2021

IDEXX Laboratories to Release 2021 Second Quarter Financial Results

  • WESTBROOK, Maine, June 30, 2021 /PRNewswire/ --  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2021 second quarter financial results for Friday, July 30, 2021 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m.
  • 06/30/2021

What's Next For IDEXX Stock After A 12% Rise In A Month?

  • The stock price of IDEXX Laboratories, an animal healthcare company, has seen a rise of 12% in the last twenty-one trading days, while it is up a large 90% over the last one year. This rise can be attributed to the multiple positive developments for the company.
  • 06/29/2021

Pandemic Boosts Animal Health Spending: 4 Stocks to Buy

  • Stocks like PetIQ (PETQ), IDEXX Laboratories (IDXX), Phibro Animal Health (PAHC) and Zoetis (ZTS) offering animal health products and services make great picks for long term.
  • 06/29/2021

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

  • Is (IDXX) Outperforming Other Medical Stocks This Year?
  • 06/23/2021

Here's Why You Should Add IDEXX (IDXX) to Your Portfolio Now

  • Investors are optimistic about IDEXX (IDXX) on strong growth in CAG business and bullish 2021 outlook.
  • 06/15/2021

Overview Of Opportunities In Animal Companionship: A $200B Industry Growing At 6.1% Annually

  • The physiological and psychological benefits that pets give us are meaningful. COVID has amplified our appreciation of this. Anticipating 6% annual growth until 2030 may be conservative, even across developed markets.
  • 06/11/2021

Up 100% in a Year, Can This Animal Health Stock Keep Climbing?

  • Not only has Heska stock doubled in a year, it has quintupled over the past five years, and it's a 20-bagger over the last decade. Why is this animal health stock flying so high?
  • 06/09/2021

Idexx Laboratories (IDXX) Gains As Market Dips: What You Should Know

  • Idexx Laboratories (IDXX) closed the most recent trading day at $560.35, moving +0.36% from the previous trading session.
  • 06/07/2021

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

  • Is (IDXX) Outperforming Other Medical Stocks This Year?
  • 06/04/2021

IDEXX (IDXX) Acquires ezyVet to Boost Practice Management Arm

  • The latest acquisition adds to IDEXX's (IDXX) cloud-based practice information management system (PIMS) segment.
  • 06/04/2021

Why IDEXX (IDXX) Could Be an Impressive Growth Stock

  • If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider IDEXX (IDXX).
  • 06/03/2021

IDEXX Acquires ezyVet

  • Global leader in veterinary diagnostics and software enhances its practice management portfolio with acquisition of leading cloud-based solution WESTBROOK, Maine, June 2, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, announced today the acquisition of ezyVet®, a fast-growing, innovative practice information management system (PIMS). With the acquisition, IDEXX further expands its world-class cloud software offerings that support customers with technology solutions that raise the standard of care for patients, improve practice efficiency, and enable more effective communication with pet owners.
  • 06/02/2021

This News Could Boost Idexx Labs' Earnings for Years to Come

  • Idexx Labs reported another strong quarter and provided more details on its new product line.
  • 06/02/2021

IDEXX Laboratories to Present at Stifel Conference and Announces 2021 Virtual Investor Day

  • WESTBROOK, Maine, May 26, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in the Stifel Virtual Jaws & Paws Conference on Wednesday, June 2, 2021. Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at 10:00 am (EDT).
  • 05/26/2021

IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q1 2021 Results - Earnings Call Transcript

  • IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q1 2021 Results - Earnings Call Transcript
  • 05/04/2021

IDEXX (IDXX) Earnings Beat Estimates in Q1, '21 View Up

  • IDEXX (IDXX) registers strong contribution from its CAG business in the first quarter despite pandemic-induced challenges.
  • 05/04/2021

Idexx Laboratories (IDXX) Q1 Earnings and Revenues Surpass Estimates

  • Idexx (IDXX) delivered earnings and revenue surprises of 36.63% and 5.87%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
  • 05/04/2021

IDEXX Laboratories Announces First Quarter Results

  • WESTBROOK, Maine, May 4, 2021 /PRNewswire/ -- Achieves reported revenue growth of 24% and organic growth of 21%, driven by CAG Diagnostics recurring revenue growth of 27% as reported and 23% organic Delivers EPS of $2.35, representing 82% growth as reported and 73% on a comparable basis Increases 2021 revenue guidance to $3,105 million - $3,160 million, reflecting higher expectations for reported growth of 14.5% - 16.5% and organic growth of 13% - 15%, supported by projected CAG Diagnostics recurring revenue growth of 16% - 17.5% as reported and 14.5% - 16% organic Raises 2021 EPS outlook to $7.88 - $8.18, reflecting expectations for 1.5% higher organic revenue growth and targeted operating margin improvement of 270 - 320 basis points as reported and 150 - 200 basis points on a comparable basis IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced first quarter results, as well as an update on U.S. companion animal diagnostics market trends. First Quarter Results The Company reports revenues of $778 million for the first quarter of 2021, an increase of 24% as reported and 21% organic.
  • 05/04/2021

Idexx Laboratories (IDXX) Stock Moves -0.66%: What You Should Know

  • In the latest trading session, Idexx Laboratories (IDXX) closed at $548.99, marking a -0.66% move from the previous day.
  • 04/30/2021

What's in Store for IDEXX Laboratories (IDXX) in Q1 Earnings?

  • IDEXX (IDXX) first-quarter top line is expected to have benefited from strength in CAG and LPD businesses.
  • 04/27/2021

Stocks This Week: Buy PayPal And Idexx Labs

  • This coming week may mark the last thrust up in this equity rally.
  • 04/25/2021

Market Rally, Leaders Suffer Further Damage: United Airlines, Freeport McMoran, Idexx Labs In Focus

  • Market rally suffers further damage, leaders hard hit: United Airlines, Freeport McMoran, Idexx Labs in focus. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.
  • 04/20/2021

IDEXX Laboratories: This Moat-Worthy Name Is Poised To Grow

  • IDEXX Laboratories is an industry leader in the field of veterinary health care, and has seen robust growth over the years. It's poised for continued growth, as it continues to scale its revenue base in the current favorable environment for pet adoptions.
  • 04/18/2021

1 Growth Driver Idexx Shareholders Should be Watching

  • The potential is staggering.
  • 04/14/2021

IDEXX Laboratories to Release 2021 First Quarter Financial Results

  • WESTBROOK, Maine, April 8, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2021 first quarter results for Tuesday, May 4, 2021 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m.
  • 04/08/2021

5 Extremely Overvalued Stocks to Sell Right Now

  • Overvalued stocks at record highs for major stock indices are too risky. These 5 stocks are too overvalued to own now.
  • 04/08/2021

3 Top Pet Healthcare Stocks to Buy Now

  • Here's how you can profit off the booming $54 billion veterinary care industry.
  • 04/05/2021

3 Top Medical Instruments Stocks to Beat COVID-19 Resurgence Crisis

  • 3 Top Medical Instruments Stocks to Beat COVID-19 Resurgence Crisis
  • 03/30/2021

5 MedTech Growth Stocks Gaining Ground in 2021 Amid Pandemic

  • Here are a few MedTech stocks, ABT, HOLX, HRC, IDXX, LMAT, which have held their ground amid the pandemic and can turn out to be wise investment choices for 2021.
  • 03/25/2021

5 Best Stocks Likely to Beat Earnings Estimates

  • These top-ranked stocks are likely to beat on the bottom lines in their next releases.
  • 03/24/2021

Idexx Laboratories (IDXX) Stock Moves -0.76%: What You Should Know

  • Idexx Laboratories (IDXX) closed at $487.66 in the latest trading session, marking a -0.76% move from the prior day.
  • 03/23/2021

IDEXX (IDXX) CAG Placement Grows Sequentially Amid COVID-19 Woes

  • IDEXX's (IDXX) Global Reference Lab revenues are growing organically in the United States and in international markets.
  • 03/22/2021

This Active Investment Fund Has Returned 18.2% Annually

  • One of the best-performing investment funds of the last decade is not a secretive Wall Street hedge fund. It's not even a private office or exchange-traded fund.
  • 03/19/2021

4 Good Companies with High Piotroski F-scores

  • In light of the Federal Reserve's announcement that it will pause interest rate hikes through 2023, investors may want to have a look at these four good companies that have strong Piotroski F-scores according to the All-in-One Screener, a Premium feature of GuruFocus: The Home Depot Inc. (NYSE:HD), IDEXX Laboratories Inc. (NASDAQ:IDXX), Moody's Corporation (NYSE:MCO) and Usana Health Sciences Inc. (NYSE:USNA).
  • 03/17/2021

The Top Holdings of the Decade's Top-Performing Gurus

  • Investors often look to top fund managers to glean information on the best strategies and generate new investment ideas.
  • 03/16/2021

Idexx Laboratories Is a Great High-Margin Growth Play

  • Investors in IDEXX stock are betting on continued growth in the company's core business and continued interest by investors in this segment. The post Idexx Laboratories Is a Great High-Margin Growth Play appeared first on InvestorPlace.
  • 03/16/2021

Here's Why You Should Add IDEXX (IDXX) to Your Portfolio Now

  • Investors are optimistic about IDEXX (IDXX) backed by robust CAG and LPD revenues growth and strong global performance boosting the top line.
  • 03/16/2021

IDEXX Laboratories (IDXX) Sees Hammer Chart Pattern: Time to Buy?

  • IDEXX Laboratories (IDXX) has been struggling lately, but the selling pressure may be coming to an end soon
  • 03/15/2021

3 Pet Med Companies Whose Growth Makes Them a Breed Apart

  • The pandemic puppy boom is real, and so are sales for these three pet stocks.
  • 03/06/2021

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

  • Is (IDXX) Outperforming Other Medical Stocks This Year?
  • 03/02/2021

Are IDEXX, Alphabet & Amazon Poised For Stock Splits In 2021?

  • The S&P 500 is up a solid 75% from the lows of March 2020 and many large-cap stocks are now trading near all-time highs. In our indicative theme of Stocks Poised For A Split, we've identified a group of over ten companies from the S&P 500 whose stocks trade at high prices, potentially making.
  • 03/01/2021

Why This Under-the-Radar Growth Stock Will Be the Top Dog in 2021

  • Idexx Labs is an animal health company putting all four feet forward.
  • 02/21/2021

Love Your Pets? Buy and Hold This Growth Stock for Life, Too

  • Idexx Labs is riding the growth trends in pet healthcare.
  • 02/19/2021

7 Pet Stocks for Animal Lovers and Investors Alike

  • Pet stocks have performed very well recently, and many analysts believe that this trend will continue as the industry grows. The post 7 Pet Stocks for Animal Lovers and Investors Alike appeared first on InvestorPlace.
  • 02/02/2021

IDEXX (IDXX) Earnings Beat Estimates in Q4, Margins Rise

  • IDEXX (IDXX) registeres strong contribution from its CAG business in the fourth quarter despite pandemic-induced challenges.
  • 02/02/2021

IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q4 2020 Results - Earnings Call Transcript

  • IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q4 2020 Results - Earnings Call Transcript
  • 02/02/2021

Idexx Laboratories (IDXX) Beats Q4 Earnings and Revenue Estimates

  • Idexx (IDXX) delivered earnings and revenue surprises of 40.56% and 5.79%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 02/02/2021

Recap: IDEXX Laboratories Q4 Earnings

  • Shares of IDEXX Laboratories (NASDAQ:IDXX) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share were up 69.23% year over year to $1.76, which beat the estimate of $1.40.
  • 02/02/2021

IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results

  • WESTBROOK, Maine, Feb. 2, 2021 /PRNewswire/ -- Achieves fourth quarter reported revenue growth of 19% and organic growth of 17%, driven by CAG Diagnostics recurring revenue reported growth of 23% and organic growth of 21% High revenue growth supported by sustained strong global trends in...
  • 02/02/2021

MedTech Stock Earnings on Feb 2: IDXX, MCK & More

  • In Q4, MedTech stocks are expected to have gained from month-wise sales rebound in many states and regions. However, international sales might have been dampened.
  • 02/01/2021

Earnings Preview for IDEXX Laboratories

  • On Tuesday, February 02, IDEXX Laboratories (NASDAQ:IDXX) will release its latest earnings report. Here is Benzinga's outlook for the company.
  • 02/01/2021

Believe It or Not, There's Something to See With Zomedica

  • There's a lot of hype around ZOM stock these days, but the name could prove to be a growth star among pet-related equities. The post Believe It or Not, There's Something to See With Zomedica appeared first on InvestorPlace.
  • 01/28/2021

What's in Store for IDEXX Laboratories (IDXX) in Q4 Earnings?

  • IDEXX's (IDXX) fourth-quarter top line is likely to have benefited from strength in CAG and LPD businesses.
  • 01/27/2021

The 3 Best Healthcare Stocks to Buy for 2021

  • These three healthcare stocks all had a good year in 2020, and their businesses look to have plenty of growth again in 2021.
  • 01/23/2021

ESG Stocks to Gather Speed Under Biden's Leadership: 5 Picks

  • Biden's administration plans to address climate change and take ESG initiatives. This call for investing in Shopify (SHOP), Magna International (MGA), IDEXX Lab (IDXX), Facebook (FB) and PayPal (PYPL).
  • 01/20/2021

ZOM Stock: Why Zomedica Shares Are on the Move Again Today

  • Zomedica shares are surging after the company updated investors on a warrant-redemption cash influx and news that its end-of-March product rollout is on track. Pet-related stocks are hot and ZOM may be on the verge of a significant breakout.
  • 01/19/2021

Growth In Pet Spending Is Off The Leash, Here Is How To Profit From It

  • Rising pet ownership rates and a steadily increasing average household spending provide a powerful tailwind to this investment theme. Pet food, animal health, veterinary equipment, and specialized e-commerce are all fields prone to profit from the secular growth trend.
  • 01/12/2021

4 of the Best Stocks to Buy for Solid Earnings Growth in 2021

  • Earnings growth is considered the most important variable in influencing the share price. Notably, some of the stocks that boast of superb earnings growth include D.R.
  • 01/12/2021

IDEXX Laboratories to Release 2020 Fourth Quarter and Full-Year Financial Results

  • WESTBROOK, Maine, Jan. 11, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2020 fourth quarter and full-year financial results for...
  • 01/11/2021

5 Soaring MedTech Stocks to Buy for More Growth in 2021

  • We have selected five MedTech growth stocks with further rooms for improvement in 2021.
  • 12/30/2020

10 Top-Performing Stocks of the S&P 500 ETF in 2020

  • If a Santa Claus rally grips Wall Street in the final days of December, the S&P 500 could see smart gains in 2020 despite the COVID-19 outbreak. These stocks helped the index to hit highs this year.
  • 12/28/2020

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

  • Is (IDXX) Outperforming Other Medical Stocks This Year?
  • 12/23/2020

8 Pet Stocks That Will Make You Purr

  • Americans love their pets, and no pandemic, not even the novel coronavirus, will change that, bolstering these eight pet stocks. The post 8 Pet Stocks That Will Make You Purr appeared first on InvestorPlace.
  • 12/23/2020

IDEXX (IDXX) Gains on CAG Sales, Global Growth Remains Robust

  • IDEXX (IDXX) sees sturdy gains in CAG Diagnostics recurring revenues, supported by high organic gains in both U.S. and International markets.
  • 12/21/2020

4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2021

  • Four large-cap MedTech stocks are currently flourishing on the back of several positive developments
  • 12/18/2020

5 MedTech Stocks That Have Outperformed the Industry in 2020

  • Here are a few MedTech stocks which continued to outperform their respective industries amid the pandemic and can turn out to be wise investment choices.
  • 12/17/2020

What Makes Idexx Laboratories (IDXX) a Strong Momentum Stock: Buy Now?

  • Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.
  • 11/27/2020

Pet Ownership Is Booming. Could These 3 Stocks Help You Profit?

  • Americans treat pets like family members, and that includes spending on specialty food, health services, and insurance.
  • 11/27/2020

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

  • Is (IDXX) Outperforming Other Medical Stocks This Year?
  • 11/20/2020

Should You Be Tempted To ‘Sell' IDEXX Laboratories (IDXX) Stock

  • Polen Capital Management recently released its Q3 2020 Investor Letter, a copy of which you can download here. During the third quarter of 2020, the Polen U.S. SMID Company Growth Composite Portfolio returned 7.11% gross of fees, while the Russell 2500 Growth Index was up 9.37%. You should check out Polen Capital's top 5 stock picks for investors to buy right now, which could be the biggest winners of this year.
  • 11/13/2020

Why It Might Be Time To Pay Attention To These 4 Red-Hot Health Stocks

  • The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
  • 11/13/2020

Which Biotech Stocks Are a Buy on Earnings?

  • If you're interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip. The post Which Biotech Stocks Are a Buy on Earnings?
  • 11/03/2020

Were Hedge Funds Right About Loading Up On IDEXX Laboratories, Inc. (IDXX)?

  • Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at delivering attractive risk-adjusted returns rather than following the ups and downs of equity markets hoping that they will outperform the broader market. Our research shows that certain hedge funds do have great stock picking skills (and we can identify these hedge funds in advance pretty accurately), so let's take a glance at the smart money sentiment towards IDEXX Laboratories, Inc. (NASDAQ:IDXX).
  • 11/02/2020

Final Trades: Caterpillar, Apollo, IDEXX & more

  • The "Halftime Report" traders give their top picks to watch for the second half.
  • 10/30/2020

2 Factors That Could Trigger a Major Market Rebound

  • Despite the recent volatility, third-quarter earnings season and a "presidential honeymoon" could set off a big market rebound in the near future. Here's more.
  • 10/29/2020

IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q3 2020 Results - Earnings Call Transcript

  • IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q3 2020 Results - Earnings Call Transcript
  • 10/29/2020

IDEXX Laboratories: Q3 Earnings Insights

  • Shares of IDEXX Laboratories (NASDAQ:IDXX) were unchanged after the company reported Q3 results.
  • 10/29/2020

Idexx Laboratories Earnings Growth Soars With Stock In Buy Zone

  • Idexx Laboratories earnings and revenue growth were the best in years for the veterinary products supplier. Shares rose after closing in a buy zone.
  • 10/29/2020

3 MedTech Growth Stocks to Scoop Up Ahead of Q3 Earnings

  • Here are three growth stocks from the MedTech space that investors can pick ahead of the quarterly releases.
  • 10/16/2020

Here's Why Momentum Investors Will Love Idexx Laboratories (IDXX)

  • Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.
  • 10/14/2020

7 Pet Stocks to Adopt Today 

  • Chewy, Zoetis and FreshPet are just a couple of the names on our list of pet stocks to buy. Let's look at this growing industry more closely.
  • 10/13/2020

Is Idexx (IDXX) a Solid Growth Stock? 3 Reasons to Think " Yes "

  • Idexx (IDXX) possesses solid growth attributes, which could help it handily outperform the market.
  • 10/13/2020

Why Idexx (IDXX) is Poised to Beat Earnings Estimates Again

  • Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
  • 10/13/2020

Top Ranked Momentum Stocks to Buy for October 13th

  • Top Ranked Momentum Stocks to Buy for October 13th
  • 10/13/2020

Idexx (IDXX) Hits 52-Week High, Can the Run Continue?

  • Idexx (IDXX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
  • 10/13/2020

Veeva Systems, Pool Corp, IDEXX: Stocks That Look Expensive, But Could Outperform

  • Our indicative theme on Expensive Performers - which includes companies trading at increasingly higher valuation multiples but are executing well, with consistently expanding Operating Margins and Revenues - is up by about 39% year-to-date on an equally weighted basis.This compares to the S&P 500.
  • 10/06/2020

IDEXX Laboratories to Release 2020 Third Quarter Financial Results

  • WESTBROOK, Maine, Oct. 5, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2020 third quarter financial results for Thursday, October 29,...
  • 10/05/2020

Betting Against IDEXX Labs Because of Coronavirus? You May Be Barking Up the Wrong Tree

  • This veterinary services-focused company has characteristics that investors love during recessions, but some metrics that may make you turtle up.
  • 09/18/2020

Idexx (IDXX) Up 2.6% Since Last Earnings Report: Can It Continue?

  • Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
  • 08/30/2020

These 5 Stocks Are The Biggest S&P 500 Healthcare Winners of 2020

  • Some of the names on this list may surprise you.
  • 08/27/2020

These 10 Stocks Are the Biggest S&P 500 Healthcare Winners of 2020

  • Savvy investors should consider adding these stocks to their portfolio to enhance its performance and diversity.
  • 08/27/2020

Idexx Laboratories Climbs Amid Rising Demand For Pet Products

  • Idexx Laboratories saw an improvement in its IBD SmartSelect Composite Rating Monday, from 94 to 96. The post Idexx Laboratories Climbs Amid Rising Demand For Pet Products appeared first on Investor's Business Daily.
  • 08/17/2020

Top Buys From The Best Money Managers (Q2 2020)

  • On August 14th, institutional investment managers with more than $100 million AUM disclosed their positions at the end of Q2 2020.
  • 08/16/2020

The Economy May Be Struggling, but the Pet Business and the Stock Market Keep Running Strong

  • Valuation discomfort can come from high stock multiples and $5-a-pound cartons of grass-fed beef for your dog
  • 08/14/2020

IDEXX Laboratories Provides U.S. Companion Animal Market Trends Update

  • IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today provided an update on U.S. Companion Animal Market Trends through Friday, July 31st. For the month of July, U.S. same-store clinical visits increased 6% and U.S. same-store total practice revenue increased 10%, reflecting continued solid trends in companion animal healthcare.
  • 08/13/2020

IDEXX Laboratories Provides U.S. Companion Animal Market Trends Update

  • WESTBROOK, Maine, Aug. 13, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc.
  • 08/13/2020

IDEXX expands ImageVue digital imaging portfolio, making enhanced radiation safety and superior diagnostic image quality affordable to more veterinarians

  • Offers higher image contrast and sharpness, plus reduces radiation dose by 25% or moreWESTBROOK, Maine, Aug. 12, 2020 /CNW/ -- IDEXX Laboratories, Inc.
  • 08/12/2020

IDEXX launches groundbreaking new ProCyte One Hematology Analyzer with dramatically simplified user experience

  • IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, announced today the launch of the ProCyte One™ Hematology Analyzer. The new analyzer's advanced technology delivers breakthrough workflow simplicity and consistent, accurate results at the point of care. The ProCyte One Hematology Analyzer is available today for pre-sale in North America and for pre-sale in select European markets later this year, with a global rollout planned for early 2021. The company expects to begin shipping in volume in the first quarter of 2021.
  • 08/12/2020

IDEXX expands ImageVue digital imaging portfolio, making enhanced radiation safety and superior diagnostic image quality affordable to more veterinarians

  • Offers higher image contrast and sharpness, plus reduces radiation dose by 25% or more WESTBROOK, Maine, Aug. 12, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc.
  • 08/12/2020

IDEXX launches groundbreaking new ProCyte One Hematology Analyzer with dramatically simplified user experience

  • Fast, effortless operation and a small footprint make consistent, accurate in-clinic hematology results accessible to veterinarians worldwide WESTBROOK, Maine, Aug. 12, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc.
  • 08/12/2020

IDEXX Laboratories to Host Virtual Investor Day

  • IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will host its 2020 virtual Investor Day on Thursday, August 13, 2020 from 10:00 am – 12:00 pm ET.
  • 08/10/2020

IDEXX Laboratories to Host Virtual Investor Day

  • WESTBROOK, Maine, Aug. 10, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc.
  • 08/10/2020

Global Veterinary Software Market 2020-2025 - Practice Management Software is Expected to Witness a Healthy CAGR - ResearchAndMarkets.com

  • The
  • 08/10/2020

Stocks To Watch: Barrick Gold, Hedge Fund Reveals And Election Plays (NASDAQ:ACIA)

  • Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
  • 08/08/2020

Idexx (IDXX) Soars to 52-Week High, Time to Cash Out?

  • Idexx (IDXX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
  • 08/03/2020

Idexx (IDXX) Soars to 52-Week High, Time to Cash Out?

  • Idexx (IDXX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
  • 08/03/2020

Zurcher Kantonalbank Zurich Cantonalbank Has $6.42 Million Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

  • Zurcher Kantonalbank Zurich Cantonalbank lowered its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 12.2% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,432 shares of the company’s stock after selling 2,696 shares during the quarter. Zurcher Kantonalbank Zurich […]
  • 08/01/2020

IDEXX Laboratories Inc (IDXX) Q2 2020 Earnings Call Transcript

  • IDXX earnings call for the period ending June 29, 2020.
  • 07/31/2020

IDEXX (IDXX) Earnings Beat Estimates in Q2, Margins Rise

  • IDEXX Laboratories (IDXX) registered strong contribution from its CAG business despite the pandemic-led challenges.
  • 07/31/2020

IDEXX (IDXX) Earnings Beat Estimates in Q2, Margins Rise

  • IDEXX Laboratories (IDXX) registered strong contribution from its CAG business despite the pandemic-led challenges.
  • 07/31/2020

Has IDEXX Laboratories (IDXX) Outpaced Other Medical Stocks This Year?

  • Is (IDXX) Outperforming Other Medical Stocks This Year?
  • 07/31/2020

IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q2 2020 Results - Earnings Call Transcript

  • IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q2 2020 Results - Earnings Call Transcript
  • 07/31/2020

Idexx Laboratories (IDXX) Beats Q2 Earnings and Revenue Estimates

  • Idexx (IDXX) delivered earnings and revenue surprises of 43.33% and 9.93%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 07/31/2020

At US$374, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?

  • Let's talk about the popular IDEXX Laboratories, Inc. (NASDAQ:IDXX). The company's shares received a lot of attention...
  • 07/31/2020

Has IDEXX Laboratories (IDXX) Outpaced Other Medical Stocks This Year?

  • Is (IDXX) Outperforming Other Medical Stocks This Year?
  • 07/31/2020

IDEXX Laboratories Announces Second Quarter Results

  • Reports revenue growth of 3% on a reported basis and 4% on an organic basis driven by Companion Animal Group Diagnostics recurring revenue growth of 7% reported and organic
  • 07/31/2020

Idexx Laboratories (IDXX) Beats Q2 Earnings and Revenue Estimates

  • Idexx (IDXX) delivered earnings and revenue surprises of 43.33% and 9.93%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 07/31/2020

IDEXX Laboratories Announces Second Quarter Results

  • WESTBROOK, Maine, July 31, 2020 /PRNewswire/ -- Reports revenue growth of 3% on a reported basis and 4% on an organic basis driven by Companion Animal Group Diagnostics recurring revenue growth of 7% reported and organic Revenue results supported by global "V-shaped" recovery in the pet.
  • 07/31/2020

Earnings Scheduled For July 31, 2020

  • Companies Reporting Before The Bell • Chevron Inc. (NYSE:CVX) is expected to report quarterly loss at $0.92 per share on revenue of $22.10 billion. • Weyerhaeuser Inc. (...
  • 07/31/2020

Should You Buy IDEXX Laboratories (IDXX) Ahead of Earnings?

  • IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
  • 07/30/2020

Should You Buy IDEXX Laboratories (IDXX) Ahead of Earnings?

  • IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
  • 07/30/2020

What's in Store for IDEXX Laboratories (IDXX) in Q2 Earnings?

  • IDEXX's (IDXX) top line is likely to have benefited from a robust CAG business and regulatory approvals for its COVID-19 tests.
  • 07/27/2020

What's in Store for IDEXX Laboratories (IDXX) in Q2 Earnings?

  • IDEXX's (IDXX) top line is likely to have benefited from a robust CAG business and regulatory approvals for its COVID-19 tests.
  • 07/27/2020

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Acquired by NEXT Financial Group Inc

  • NEXT Financial Group Inc increased its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 22.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,739 shares of the company’s stock after acquiring an additional 319 shares during the quarter. NEXT Financial Group Inc’s holdings in […]
  • 07/27/2020

3 Great Healthcare Stocks to Watch

  • There’s a lot to like about investing in the healthcare sector, so get to know three stocks that make great investments right now.
  • 07/24/2020

Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?

  • Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
  • 07/21/2020

Are You Looking for a Top Momentum Pick? Why Idexx Laboratories (IDXX) is a Great Choice

  • Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.
  • 07/21/2020

Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?

  • Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
  • 07/21/2020

Are You Looking for a Top Momentum Pick? Why Idexx Laboratories (IDXX) is a Great Choice

  • Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.
  • 07/21/2020

IDEXX Laboratories to Release 2020 Second Quarter Financial Results and Host Virtual Investor Day

  • IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2020 second quarter financial results for Friday, July 31, 2020 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
  • 07/20/2020

Investing For The Long Run: How To Analyze 'Expert' Advice

  • My Great Reset Investment Matrix is a helpful guide for analyzing ideas -- including those of famous experts.
  • 07/19/2020

Investing Ideas For The Long Run: Analyzing 'Expert' Advice

  • Stocks Analysis by Jeff Miller covering: Citigroup Inc, Alphabet Inc Class A, Amazon.com Inc, Western Union Company. Read Jeff Miller's latest article on Investing.com
  • 07/19/2020

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Acquired by Harel Insurance Investments & Financial Services Ltd.

  • Harel Insurance Investments & Financial Services Ltd. raised its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 55.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 448 shares of the company’s stock after purchasing an additional 160 shares during the quarter. […]
  • 07/16/2020

Louisiana State Employees Retirement System Has $1.22 Million Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

  • Louisiana State Employees Retirement System raised its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 2.8% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 3,700 shares of the company’s stock after acquiring an additional 100 shares during the period. Louisiana State Employees Retirement System’s holdings in IDEXX […]
  • 07/16/2020

Did Hedge Funds Make The Right Call On IDEXX Laboratories, Inc. (IDXX) ?

  • At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. […]
  • 07/14/2020

Why IDEXX Laboratories (IDXX) Stock is a Compelling Investment Case

  • Baron Asset Fund recently published its second-quarter commentary – a copy of which can be downloaded here. During the second quarter of 2020, the Baron Asset Fund returned 28.02% (institutional shares). In comparison, the benchmark S&P; 500 Index was up 20.54%, while the Russell Midcap Growth Index was up 30.26%. You should check out Baron […]
  • 07/13/2020

Baron Funds Q2 2020 Andrew Peck Letter

  • Baron is an asset management firm focused on delivering growth equity investment solutions known for long-term, fundamental, active approach to growth investing.
  • 07/13/2020

Carroll Financial Associates Inc. Grows Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

  • Carroll Financial Associates Inc. grew its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 50.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 269 shares of the company’s stock after buying an additional 90 shares during the quarter. Carroll Financial […]
  • 07/13/2020

IDEXX Gains on Diagnostics Revenues, New Coronavirus Tests

  • IDEXX's (IDXX) human health business, OPTI Medical Systems' newly-developed PCR laboratory test kit named OPTI SARS-CoV-2 RNA RT-PCR gains market acceptance.
  • 07/03/2020

IDEXX Gains on Diagnostics Revenues, New Coronavirus Tests

  • IDEXX's (IDXX) human health business, OPTI Medical Systems' newly-developed PCR laboratory test kit named OPTI SARS-CoV-2 RNA RT-PCR gains market acceptance.
  • 07/03/2020

IDEXX Gains on Diagnostics Revenues, New Coronavirus Tests

  • Stocks Analysis by Zacks Investment Research covering: Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated. Read Zacks Investment Research's latest article on Investing.com
  • 07/03/2020

Watch briefing: Gov. Mills to speak on reopening, as Maine reports 41 new coronavirus cases

  • Another stage of reopening begins Wednesday, as movie theaters, performing arts venues, bowling alleys, amusement parks and spas get a green light to open their doors, provided they follow state protocols.
  • 07/01/2020

Rumi (cat) needs forever home

  • One of your neighbors posted in Community Corner. Click through to read what they have to say. (The views expressed in this post are the author’s own.)
  • 06/30/2020

Rumi (cat) needs forever home ASAP

  • One of your neighbors posted in Neighbor News. Click through to read what they have to say. (The views expressed in this post are the author’s own.)
  • 06/30/2020

CIO Leadership: HMG Strategy Soars to #1 in Virtual Events for CIOs, CISOs and Technology Executives – Next Up: Virtual Summits in Philadelphia, New York Financial Services and Silicon Valley

  • HMG Strategy, the world's #1 digital platform for connecting technology executives to reimagine the enterprise and reshape the business world, is excited to
  • 06/29/2020

HOLX vs. IDXX: Which Stock Is the Better Value Option?

  • HOLX vs. IDXX: Which Stock Is the Better Value Option?
  • 06/29/2020

HOLX vs. IDXX: Which Stock Is the Better Value Option?

  • HOLX vs. IDXX: Which Stock Is the Better Value Option?
  • 06/29/2020

State of Tennessee Treasury Department Sells 267 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

  • State of Tennessee Treasury Department lowered its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 1.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,169 shares of the company’s stock after selling 267 shares during the […]
  • 06/28/2020

Global Companion Animal Diagnostics Market (2020 to 2025) - Rising Demand for Pet Insurance is Driving the Market - ResearchAndMarkets.com

  • The
  • 06/25/2020

Coronavirus takes another Maine life, as active cases decline

  • The death reported Wednesday brings the Maine toll from COVID-19 to 103 since the pandemic began in March, but the total number of active cases is declining.
  • 06/24/2020

Assessment of COVID-19's Effect on Small Animal Imaging Market 2020-2024 | Rising Demand for Pet Insurance to Augment Growth | Technavio

  • The Global Small Animal Imaging Market will grow by USD 959.08 mn during 2020-2024
  • 06/19/2020

These 7 Pet Care Stocks Will Reduce the Cost of Pet Ownership

  • Global pet care sales could hit $203 billion by 2025. Here are seven pet care stocks to buy from the only pet care ETF in the U.S.
  • 06/18/2020

These 7 Pet Care Stocks Will Reduce the Cost of Pet Ownership

  • The ProShares Pet Care ETF is the only ETF dedicated to pet stocks
  • 06/18/2020

‘We dodged a lot of bullets’: Quick action at Cape Memory Care limited virus cases in community

  • The state's rapid, widespread testing of the residents and staff at the congregate care facility in Cape Elizabeth, coupled with quarantines and tracking and tracing of close contacts, helped contain the spread of COVID-19.
  • 06/17/2020

Veterinary Immunodiagnostics Industry Report - Global Outlook and Forecast to 2028 - ResearchAndMarkets.com

  • The
  • 06/17/2020

One more death and 17 new COVID-19 cases reported in Maine

  • While the number of coronavirus cases tracked by the Maine Center for Disease Control and Prevention continues to increase, deaths of individuals with COVID-19 have remained relatively flat.
  • 06/15/2020

Quadrupling of state lab’s COVID-19 testing capacity puts Maine in good position, public health experts say

  • Beefing up contact tracing and disclosing data about it is the new challenge as the state continues its phased reopening plan.
  • 06/14/2020

20 Stocks That Are Vulnerable if 2017 Tax Cuts Are Rolled Back

  • As the U.S. election nears, strategists expect volatility as investors try to game out what the results could mean for their portfolios and for tax policy.
  • 06/13/2020

CIO Leadership: HMG Strategy Looks Ahead to UK, Charlotte and St. Louis CIO Virtual Summits After Vaulting to #1 in Virtual Events for CIOs, CTOs, CISOs and Technology Executives

  • HMG Strategy, the world's #1 digital platform for connecting technology executives to reimagine the enterprise and reshape the business world, excitedly
  • 06/12/2020

Forum: Changes in the COVID-19 response

  • June is here. In Maine, that usually means days at camp, visits to the beach, hikes, bonfires and lobster dinners. This year, June also means a new stage in the state’s reopening plan. With a pandemic going on around us, it’s hard to know exactly how to act or how to spend our time, but …
  • 06/12/2020

These 2 States Now Require Summer Visitors To Take A COVID-19 Test

  • Summer vacationers have a not-so-difficult choice: Get tested or self-quarantine.
  • 06/12/2020

US Indexes Mostly Lower Again Wednesday

  • Nasdaq reports another new high Continue reading...
  • 06/10/2020

Maine marks a grim milestone: 100th death from COVID-19

  • State health officials reported the 100th death Tuesday, as well as 18 new cases as expanded testing continues.
  • 06/09/2020

COVID-19 Impact and Recovery Analysis- Veterinary Diagnostic Devices Market 2020-2024 | Rising Demand for Pet Insurance to Boost Growth | Technavio

  • The Global Veterinary Diagnostic Devices Market will grow by USD 815.28 mn during 2020-2024
  • 06/09/2020

Europe Animal Healthcare Market Analysis and Demand With Forecast Overview To 2026

  • Jun 08, 2020 (Market Insight Reports) -- Selbyville, Delaware: Europe Animal Healthcare market report studies the industry based on one or more segments...
  • 06/08/2020

Maine eases quarantine rule for visitors as virus testing expands

  • Vermont and New Hampshire residents will not have to quarantine, and other visitors can avoid the 14-day quarantine if they certify they have tested negative for COVID-19 within 72 hours before checking in to a Maine lodging.
  • 06/08/2020

Maine lifts some tourism restrictions, announces plan to quadruple testing capacity in July - The Boston Globe

  • Maine announced it will quadruple its coronavirus testing capacity in July, as the state reported 18 new cases of the virus and no new deaths.
  • 06/08/2020

IDEXX OPTI Medical Gets CE Mark for RT-PCR Coronavirus Test

  • This test by IDEXX (IDXX) benefits from an optimized workflow and claims to deliver greater assurance of quality and accuracy.
  • 06/08/2020

IDEXX OPTI Medical Gets CE Mark for RT-PCR Coronavirus Test

  • This test by IDEXX (IDXX) benefits from an optimized workflow and claims to deliver greater assurance of quality and accuracy.
  • 06/08/2020

Idexx Unit Gets European Union Regulatory Nod For Covid-19 Test Kit

  • Idexx Laboratories Inc.’s (IDXX) subsidiary Opti Medical Systems, Inc., announced that it has received the European Union’s regulatory CE mark approval for its laboratory test kit for the detection of SARS-CoV-2, the virus that causes COVID-19.The Opti SARS-CoV-2 test kit uses real-time reverse transcription polymerase chain reaction (RT-PCR) technology and is developed to provide results in about 2–3.5 hours."The CE mark certification is an important step in advancing our efforts to support critical COVID-19 testing,” said Olivier te Boekhorst, Corporate VP and General Manager of Opti Medical Systems. “We are committed to helping our communities around the globe and will continue to work with regulatory authorities and customers to expand the availability of diagnostic testing.”In addition, the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for Opti’s DNA/RNA magnetic bead kit for nucleic acid extraction from respiratory samples to be used with the Opti SARS-CoV-2 RT-PCR test kit. This will enable Opti Medical Systems to provide laboratories with a complete manufactured workflow solution for COVID-19 testing, the company said.Opti’s RT-PCR laboratory test kit has previously been approved by the Institut Pasteur of France and has also received EUA by the FDA.Shares in Idexx Laboratories have climbed about 70% since reaching a multi-year low in March. The stock rose 0.5% to $311.71 as of Friday’s close.Five-star analyst Erin Wright at Credit Suisse recently reiterated his Buy rating on the stock with a $300 price target, as weekly clinical visit trends turn positive.“While we acknowledge near-term COVID-19 headwinds remain, the reported patient visit growth underscores our view of IDXX as a compelling alternative investment, with durable revenues and consistent price realization in a healthy longer term fundamental backdrop, contributing to greater predictability and visibility on growth,” Wright wrote in a note to investors.The rest of the Wall Street analyst community is cautiously optimistic on Idexx stock. The Moderate Buy consensus consists of 3 Buy versus 2 Hold ratings. The $300.75 average price target now indicates 3.5% downside potential in the shares, following the sharp rally this year. (See Idexx stock analysis on TipRanks).Related News: AbbVie Announces Partnership To Develop Novel Covid-19 Antibody Therapy Emergent Bio Plunges 14% Post-Market After Directors Divest Shares 5 Promising Covid-19 Vaccines Picked For Trump’s Operation Warp Speed More recent articles from Smarter Analyst: * Boeing (BA) Stock Probably Rallied Too Far, Too Fast * Latam Airlines' Shares Could Be Heading Further South; Top Analyst Says 'Sell' * Starbucks’ (SBUX) Road to Recovery Will Take Longer Than Anticipated, Says Analyst * TripAdvisor: Post Pandemic, Many Challenges Await
  • 06/07/2020

Ladislas Nzeyimana: Deering High School

  • He has become a school and community leader after only four years in the United States.
  • 06/07/2020

Private Advisor Group LLC Sells 2,756 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

  • Private Advisor Group LLC decreased its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 35.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,939 shares of the company’s stock after selling 2,756 shares during the period. Private Advisor […]
  • 06/07/2020

Is IDEXX Laboratories, Inc. (IDXX) A Good Stock To Buy?

  • Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]
  • 06/05/2020

OPTI Medical Systems Receives CE Mark for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19

  • OPTI Medical Systems, Inc., a subsidiary of IDEXX Laboratories, Inc. (NASDAQ: IDXX), today announced that it has received the CE mark certification in the European Union for its OPTI® SARS-CoV-2 RT-PCR laboratory test kit for the detection of SARS-CoV-2, the virus that causes COVID-19. This announcement follows earlier validation of the test by the Institut Pasteur of France as well as Emergency Use Authorization (EUA) by the United States Food and Drug Administration (FDA).
  • 06/05/2020

OPTI Medical Systems Receives CE Mark for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19

  • ROSWELL, Ga., and WESTBROOK, Maine, June 5, 2020 /PRNewswire/ -- OPTI Medical Systems, Inc., a subsidiary of IDEXX Laboratories, Inc. (NASDAQ: IDXX), today announced that it has received the CE mark certification in the European Union for its OPTI® SARS-CoV-2 RT-PCR laboratory test kit...
  • 06/05/2020

Stocks That Hit 52-Week Highs On Thursday

  • 06/04/2020

Stocks That Hit 52-Week Highs On Wednesday

  • 06/03/2020

Veterinary Rapid Tests Market 2020-2024 | Increasing Prevalence of Zoonotic Diseases to Boost Growth | Technavio

  • The Global Veterinary Rapid Tests Market will grow by $ 228.69 bn during 2020-2024
  • 06/03/2020

Stocks That Hit 52-Week Highs On Monday

  • 06/01/2020

Idexx (IDXX) Up 11.3% Since Last Earnings Report: Can It Continue?

  • Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
  • 05/30/2020

Idexx (IDXX) Up 11.3% Since Last Earnings Report: Can It Continue?

  • Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
  • 05/30/2020

The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%

  • NEW YORK, May 29, 2020 /PRNewswire via COMTEX/ -- NEW YORK, May 29, 2020 /PRNewswire/ -- The global veterinary point-of-care diagnostics market is projected...
  • 05/29/2020

Stocks That Hit 52-Week Highs On Thursday

  • 05/28/2020

Zacks.com featured highlights include: Myriad Genetics, Cinemark, Vericel and IDEXX Laboratories

  • Zacks.com featured highlights include: Myriad Genetics, Cinemark, Vericel and IDEXX Laboratories
  • 05/27/2020

IDEXX Sees Higher Clinical Visits Despite Coronavirus Crisis

  • IDEXX (IDXX) notes a significant improvement in U.S. clinical visit trends across major regions.
  • 05/27/2020

IDEXX Sees Higher Clinical Visits Despite Coronavirus Crisis

  • IDEXX (IDXX) notes a significant improvement in U.S. clinical visit trends across major regions.
  • 05/27/2020

IDEXX Laboratories Provides U.S. Companion Animal Market Trends Update

  • IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today provided an update on U.S. Companion Animal Market Trends through Friday, May 22nd.
  • 05/26/2020

Maine to expand contact tracing for coronavirus exposures

  • The state will use $7.5 million in federal funds to hire more staff to identify those who may have had contact with infected people, and it is using new technology to allow people in quarantine to report symptoms.
  • 05/26/2020

Dump These 4 Toxic Stocks or Sell Short for Timely Profits

  • Identifying toxic stocks and discarding them at the right time is the key to guard your portfolio from big losses.
  • 05/26/2020

Dump These 4 Toxic Stocks or Sell Short for Timely Profits

  • Identifying toxic stocks and discarding them at the right time is the key to guard your portfolio from big losses.
  • 05/26/2020

Great Animal Imaging Market Boosting the Growth Worldwide: 2026 Market Key Dynamics, Recent and Future Demand, Trends, Share Valuation Industry Size and Foreseen Research Report

  • May 26, 2020 (Profound via COMTEX) -- Great Animal Imaging Market 2020 Report offers a professional and in-depth study on the current state of the Global...
  • 05/26/2020

Global Animal Pharmaceuticals Market (2020 to 2025) - By Product Type, Product, Animal Type, Registration, Region, Forecast & Opportunities - ResearchAndMarkets.com

  • The
  • 05/26/2020

Veterinary Diagnostic Imaging Market Size, Share and Global Outlook During 2020 to 2026; Toshiba, Carestream Health, BCF Technology

  • May 25, 2020 (Market Insight Reports) -- The Veterinary Diagnostic Imaging Market recently published a Global Market research study with more than 100...
  • 05/25/2020

Insider Weekends: Moderna Executives Go On A Selling Spree

  • Insider buying decreased significantly last week. Notable Insider Buys: Mercury General Corporation, Cortexyme, Inc., New Mountain Finance Corporation, Berkshir
  • 05/25/2020

Have $1,000 to Invest? Billionaires Are Buying These 3 Stocks

  • You could ask 100 different analysts what they think about buying and selling stocks during COVID-19, and you might just get 100 different opinions. If you have $1,000 to invest, now could be a great opportunity to start a new position, and billion-dollar hedge fund managers have been scooping up shares of IDEXX Laboratories (NASDAQ: IDXX), Goodyear Tire (NASDAQ: GT) and Starbucks (NASDAQ: SBUX). You may not recognize IDEXX Laboratories, but if you're a pet owner there's a chance you've crossed paths with its products or services already.
  • 05/25/2020

Have $1,000 to Invest? Billionaires Are Buying These 3 Stocks

  • It's easy to see why the smart money is moving into these three stocks.
  • 05/25/2020

Research Report with COVID-19 Forecasts- Animal Health Diagnostics Market 2020-2024 | Rising Pet Adoption to Boost Growth | Technavio

  • The animal health diagnostics market is poised to grow by USD 1.69 bn during 2020-2024, according to Technavio
  • 05/23/2020

CIO Leadership: HMG Strategy Smashes Attendance Records with its Silicon Valley CISO Virtual Summit on May 21 – Next Up: Denver CIO Virtual Summit

  • In the latest in its ongoing series of HMG Live! Virtual CIO and CISO Summits, HMG Strategy is excited to announce that its Silicon Valley CISO Virtual Summit
  • 05/22/2020

Urgent care, walk-in clinics making virus tests easier to get in Maine

  • Expanded testing will also include drive-through sites, although patients still will need to be screened by medical providers before being tested.
  • 05/22/2020

State reports new outbreak of 57 cases at long-term care facility in Cape Elizabeth

  • The outbreak at Cape Memory Care is the largest reported at one time in Maine, and more test results are still pending.
  • 05/21/2020

Maine sees jump in coronavirus infections with 78 new cases

  • Wednesday's spike is attributed in part to increased testing capacity at state and private labs, and comes at a time when the racial gap among those with COVID-19 is growing.
  • 05/20/2020

Maine delays gym openings as CDC reports 3 deaths, 28 additional COVID-19 cases

  • While the reopening of gyms, fitness centers and nail salons will be delayed because of concerns about virus transmission, campgrounds will be allowed to reopen this weekend to Maine residents, about a week ahead of the original plan.
  • 05/19/2020

IDEXX Laboratories to Present at Stifel Conference

  • IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in the Stifel Virtual Jaws & Paws Conference on Wednesday, May 27, 2020. Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at 9:45 am EDT.
  • 05/18/2020

Stocks That Hit 52-Week Highs On Monday

  • 05/18/2020

IDEXX Laboratories to Present at Stifel Conference

  • WESTBROOK, Maine, May 18, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in the Stifel Virtual Jaws & Paws Conference on Wednesday, May 27, 2020. Jay...
  • 05/18/2020

Google Stock And Two Others Join IBD's Long-Term Leaders Watchlist

  • Google stock forms a bullish cup base. It joins IBD's Long-Term Leaders Watchlist along with two others.
  • 05/15/2020

Night Owl Capital Management, LLC Buys Fidelity National Information Services Inc, Aon PLC, ...

  • 05/15/2020

Summit Global Investments Buys Amazon.com Inc, Clorox Co, Adobe Inc, Sells NVR Inc, TJX Inc, ...

  • 05/14/2020

The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter

  • Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Acceleron Pharma Inc (NASDAQ...
  • 05/13/2020

MayTech Global Investments, LLC Buys Facebook Inc, Sea, Livongo Health Inc, Sells iShares Core ...

  • 05/12/2020

Veterinary Diagnostics Market to Reach US$ 5.4 Bn by 2027

  • May 11, 2020 (Market Prediction via COMTEX) -- The global Veterinary Diagnostics Market is projected to reach more than US$ 5.4 Billion By 2027 with a CAGR...
  • 05/11/2020

Blair William & Co Buys Apple Inc, Microsoft Corp, Amazon.com Inc

  • 05/11/2020

Mills announces accelerated reopening for retail stores, restaurants in 12 rural counties

  • The announcement comes one day after Gov. Janet Mills unveiled a deal with Westbrook-based Idexx that will allow the state's public health lab to triple its testing capacity.
  • 05/08/2020

Stocks That Hit 52-Week Highs On Friday

  • 05/08/2020

Benzinga Pro's Top 5 Stocks To Watch For Fri., May 8, 2020: KC, IDXX, LAZY, AQST, AN

  • Today's 5 Stock Ideas: * Kingsoft Cloud (KC) \- A new issue expected to open Friday morning. The company is one of China's top cloud service providers. Shares were expected in the $16-$18/share range and priced right in the middle at $17/share. * IDEXX (IDXX) \- A play on coronavirus testing. The company reported its OPTI Medical subsidiary was granted FDA Emergency Use Authorization for OPTI coronavirus lab test kit. * Lazydays (LAZY) \- A play on the RV market. Public health workers and nurses have recently used RVs as a way to effectively separate their home environment from their families. * Aquestive Therapeutics (AQST) \- A play on an upcoming FDA date. The company is expected see an FDA PDUFA action date for its Parkinson's treatment New Drug Application within the next two weeks. * AutoNation (AN) ​- An earnings play. The company will report quarterly results before the market open on Monday.See more from Benzinga * Benzinga Pro's Top 5 Stocks To Watch For Fri., Apr. 3, 2020: USIO, NTDOY, AJRD, AN, OTIS(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
  • 05/08/2020

Dai-Ichi Life Insurance Company, Ltd Buys Lockheed Martin Corp, Bright Horizons Family ...

  • 05/08/2020

Maine to triple its virus testing capacity in partnership with Idexx

  • Gov. Janet Mills says that, soon, anyone who needs a coronavirus test will be able to get one.
  • 05/07/2020

'Gov. Mills says Maine is about to triple the number of #COVID19 tests in the state in partnership with IDEXX, allowing anyone in Maine suspected of having the virus to get a test' -Tweet

  • 05/07/2020

IDEXX Labs Reports Its OPTI Medical Subsidiary Granted FDA Emergency Use Authorization For OPTI Coronavirus Lab Test Kit

  • 05/07/2020

OPTI Medical Systems Receives US FDA Emergency Use Authorization for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19

  • OPTI Medical Systems, Inc., a subsidiary of IDEXX Laboratories, Inc. (NASDAQ: IDXX), today announced that the United States Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the OPTI® SARS-CoV-2 RT-PCR laboratory test kit for the detection of SARS-CoV-2, the virus that causes COVID-19. This announcement follows earlier validation of the test by the Institut Pasteur of France.
  • 05/07/2020

Cqs (us), Llc Buys Merck Inc, Johnson & Johnson, Kimberly-Clark Corp, Sells Discovery Inc, ...

  • 05/07/2020

Elanco Animal Health: An Unnoticed Stock With Potential

  • Elanco Animal Health Inc. is buying Bayer’s animal health unit. Elanco has underperformed the overall market and rivals. With new product launches, Elanco looks
  • 05/06/2020

Veterinary Reference Laboratory (VRL) Market 2020 | COVID -19 Research Report- IDEXX Laboratories, Inc., VCA, Inc., GD Animal Health, Greencross Ltd

  • May 05, 2020 Xherald -- Veterinary Reference Laboratory (VRL) Market report will make detailed analysis mainly on in-depth research on the development...
  • 05/05/2020

Stifel Maintains Buy on IDEXX Laboratories, Raises Price Target to $280

  • 05/01/2020

IDEXX Laboratories Inc (IDXX) Q1 2020 Earnings Call Transcript

  • IDXX earnings call for the period ending March 31, 2020.
  • 05/01/2020

Edited Transcript of IDXX earnings conference call or presentation 30-Apr-20 12:30pm GMT

  • Q1 2020 IDEXX Laboratories Inc Earnings Call
  • 04/30/2020

IDEXX Laboratories, Inc.'s (IDXX) CEO Jay Mazelsky on Q1 2020 Results - Earnings Call Transcript

  • IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2020 Results Earnings Conference Call April 30, 2020, 8:30 AM ET Company Participants Jay Mazelsky - President and CEO
  • 04/30/2020

Idexx Laboratories Tops Q1 Estimates Despite COVID-19 Impact

  • The company withdrew its full-year guidance because of the COVID-19 pandemic but is seeing some signs of improvement in April.
  • 04/30/2020

IDEXX Laboratories, Inc.'s (IDXX) CEO Jay Mazelsky on Q1 2020 Results - Earnings Call Transcript

  • IDEXX Laboratories, Inc.'s (IDXX) CEO Jay Mazelsky on Q1 2020 Results - Earnings Call Transcript
  • 04/30/2020

IDEXX: The Size Of The Fight In The Dog

  • “What counts is not the size of the dog in the fight - it's the size of the fight in the dog” (Mark Twain); COVID-19 will probably hurt IDEXX, but this company
  • 04/30/2020

IDEXX (IDXX) Q1 Earnings Top Estimates, Margins Decline

  • IDEXX Laboratories (IDXX) companion animal clinical visits decrease due to the impact of the coronavirus pandemic.
  • 04/30/2020

IDEXX (IDXX) Q1 Earnings Top Estimates, Margins Decline

  • IDEXX Laboratories (IDXX) companion animal clinical visits decrease due to the impact of the coronavirus pandemic.
  • 04/30/2020

Idexx Laboratories Tops Q1 Estimates Despite COVID-19 Impact

  • The company withdrew its full-year guidance because of the COVID-19 pandemic but is seeing some signs of improvement in April.
  • 04/30/2020

Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates

  • Idexx (IDXX) delivered earnings and revenue surprises of 4.88% and -0.86%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 04/30/2020

Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates

  • Idexx (IDXX) delivered earnings and revenue surprises of 4.88% and -0.86%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 04/30/2020

IDEXX (IDXX) Q1 Earnings Top Estimates, Margins Decline

  • IDEXX Laboratories (IDXX) companion animal clinical visits decrease due to the impact of the coronavirus pandemic.
  • 04/30/2020

Idexx: 1Q Earnings Snapshot

  • WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Thursday reported first-quarter profit of $111.8 million. On a per-share basis, the Westbrook, Maine-based company said it had profit of $1.29. The results beat Wall Street expectations. The a
  • 04/30/2020

Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates

  • Idexx (IDXX) delivered earnings and revenue surprises of 4.88% and -0.86%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
  • 04/30/2020

IDEXX Laboratories Q1 EPS $1.290 Beats $1.200 Estimate, Sales $626.336M Beat $617.410M Estimate

  • 04/30/2020

Notable earnings before Thursday's open

  • AAL, ABMD, AGIO, AIMC, AIT, AMRN, ARW, ASPS, AUY, BAX, BC, BEN, BPOP, CFR, CG, CHD, CI, CMCSA, COLB, COP, COR, CRS, CWT, DAN, DNKN, DOW, EME, ESI, ETN, FBP, FCN, FLWS, GNRC, GRA, GT, HBI, HGV, HUBB, I
  • 04/29/2020

IDEXX Laboratories Q1 2020 Earnings Preview

  • IDEXX Laboratories (NASDAQ:IDXX) is scheduled to announce Q1 earnings results on Thursday, April 30th, before market open.The consensus EPS Estimate is $1.20 (+2.6% Y/Y) and the consensus Revenue Esti
  • 04/29/2020

Medical Products Stock Earnings on Apr 30: BAX, IDXX & More

  • The medical product companies have partially mitigated the impact of the pandemic driven by the massive adoption of COVID-19 related healthcare-support products and services.
  • 04/29/2020

Medical Products Stock Earnings on Apr 30: BAX, IDXX & More

  • The medical product companies have partially mitigated the impact of the pandemic driven by the massive adoption of COVID-19 related healthcare-support products and services.
  • 04/29/2020

BBVA USA Bancshares Inc. Buys 135 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

  • BBVA USA Bancshares Inc. lifted its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 4.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,311 shares of the company’s stock after acquiring an additional 135 shares during the period. BBVA USA Bancshares Inc.’s […]
  • 04/29/2020

Can my dog or cat get coronavirus? What pet owners need to know after a pug and two cats tested positive in the U.S.

  • Here’s how to take care of pets during the COVID-19 pandemic
  • 04/28/2020

Clarius Group LLC Acquires 77 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

  • Clarius Group LLC raised its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 8.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 947 shares of the company’s stock after acquiring an additional 77 shares during the period. Clarius Group LLC’s […]
  • 04/28/2020

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Short Interest Up 37.1% in April

  • IDEXX Laboratories, Inc. (NASDAQ:IDXX) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 2,070,000 shares, a growth of 37.1% from the March 31st total of 1,510,000 shares. Based on an average daily volume of 713,700 shares, the days-to-cover ratio is […]
  • 04/28/2020

Torray LLC Buys Bristol-Myers Squibb Company, Sysco Corp, DuPont de Nemours Inc, Sells General ...

  • 04/28/2020

Hartford Investment Management Co. Has $2.26 Million Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

  • Hartford Investment Management Co. grew its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 3.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,317 shares of the company’s stock after purchasing an additional 317 shares during the period. Hartford Investment Management Co.’s holdings in IDEXX […]
  • 04/27/2020

Top-Rated Idexx Laboratories Near Buy Zone With Earnings Due

  • 04/27/2020

Cribstone Capital Management LLC Has $1.49 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

  • Cribstone Capital Management LLC decreased its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 2.5% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,165 shares of the company’s stock after selling 155 shares during the quarter. IDEXX Laboratories accounts for approximately 1.6% of […]
  • 04/26/2020

Analysts Expect IDEXX Laboratories, Inc. (NASDAQ:IDXX) Will Announce Quarterly Sales of $631.77 Million

  • Equities research analysts expect IDEXX Laboratories, Inc. (NASDAQ:IDXX) to post sales of $631.77 million for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for IDEXX Laboratories’ earnings, with the lowest sales estimate coming in at $625.20 million and the highest estimate coming in at $637.50 million. IDEXX Laboratories posted sales of $576.06 […]
  • 04/26/2020

Cabot Wealth Management Inc. Has $978,000 Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

  • Cabot Wealth Management Inc. trimmed its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 1.6% during the first quarter, Holdings Channel reports. The firm owned 4,037 shares of the company’s stock after selling 65 shares during the quarter. Cabot Wealth Management Inc.’s holdings in IDEXX Laboratories were worth $978,000 at the end of the most recent […]
  • 04/24/2020

Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth

  • Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 04/23/2020

Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth

  • Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 04/23/2020

What's in Store for IDEXX Laboratories (IDXX) in Q1 Earnings?

  • IDEXX's (IDXX) business is likely to have benefited from few cases in which pets were found to be COVID-19 positive globally.
  • 04/23/2020

What's in Store for IDEXX Laboratories (IDXX) in Q1 Earnings?

  • IDEXX's (IDXX) business is likely to have benefited from few cases in which pets were found to be COVID-19 positive globally.
  • 04/23/2020

Two New York cats become first U.S. pets to test positive for COVID-19

  • ***
  • 04/23/2020

Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth

  • Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 04/23/2020

What's in Store for IDEXX Laboratories (IDXX) in Q1 Earnings?

  • IDEXX's (IDXX) business is likely to have benefited from few cases in which pets were found to be COVID-19 positive globally.
  • 04/23/2020

IDEXX Laboratories (IDXX) Scheduled to Post Earnings on Thursday

  • IDEXX Laboratories (NASDAQ:IDXX) is scheduled to be releasing its earnings data before the market opens on Thursday, April 30th. Analysts expect IDEXX Laboratories to post earnings of $1.21 per share for the quarter. IDEXX Laboratories has set its FY 2020 Pre-Market guidance at 5.42-5.58 EPS and its FY20 guidance at $5.42-5.58 EPS.Persons that are interested […]
  • 04/23/2020

Two New York cats become first U.S. pets to test positive for COVID-19

  • Two cats in New York have become the first pets in the United States to test positive for the new coronavirus but there is no evidence pets can spread the virus to humans, according to U.S. health …
  • 04/23/2020

UPDATE 2-Two New York cats become first U.S. pets to test positive for COVID-19

  • Two cats in New York have become the first pets in the United States to test positive for the new coronavirus but there is no evidence pets can spread the virus to humans, according to U.S. health authorities.
  • 04/23/2020

Anderson Hoagland & Co Buys Vanguard Total Stock Market, Microsoft Corp, Alibaba Group ...

  • 04/23/2020

Edited Transcript of CEVI.ST earnings conference call or presentation 22-Apr-20 9:00am GMT

  • Q1 2020 CellaVision AB Earnings Call
  • 04/22/2020

IDEXX Laboratories: A Best-In-Breed Growth Company

  • IDEXX Laboratories sports an impressive return on invested capital and the business is benefiting from increased spending on pets. IDEXX shares have appreciated
  • 04/22/2020

400 Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Bought by CENTRAL TRUST Co

  • CENTRAL TRUST Co purchased a new position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 400 shares of the company’s stock, valued at approximately $97,000. A number of other institutional investors and hedge funds also recently modified […]
  • 04/22/2020

Assenagon Asset Management S.A. Sells 12,892 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

  • Assenagon Asset Management S.A. cut its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 66.5% in the 1st quarter, HoldingsChannel reports. The fund owned 6,505 shares of the company’s stock after selling 12,892 shares during the period. Assenagon Asset Management S.A.’s holdings in IDEXX Laboratories were worth $1,576,000 as of its most recent SEC […]
  • 04/22/2020

Congress Asset Management Co Buys Ciena Corp, Huntington Ingalls Industries Inc, Akamai ...

  • 04/21/2020

Stay-home foes heading to Augusta; elders getting groceries

  • PORTLAND, Maine (AP) — The latest demonstration aimed at reopening the economy as the coronavirus pandemic eases and ending stay-at-home restrictions is scheduled to take place in Maine's capital city on Monday. Similar rallies have happened in New Hampshire, Michigan and elsewhere in the country, with participants including gun rights activists, opponents of stay-at-home orders and fans of Republican President Donald Trump. Maine's event is organized by Republican State Rep. Chris Johansen, of Aroostook County. Johansen has urged participants in the rally to maintain social distance, wear masks and abstain from openly carrying guns. He has also used social media to call on demonstrators to “fill up your gas tanks and get ready to rumble" in Augusta. The event will include a “motor brigade,” in which residents will circle the governor's mansion in vehicles, and a sidewalk rally. Johansen has told participants to wear Trump's signature “Make American Great Again” hats and bring bullhorns. Social media posts about the demonstration direct their ire at Democratic Gov. Janet Mills, who has placed the state under a stay-at-home order. ___ REPUBLICANS VOICE CONCERNS Dozens of Republican lawmakers sent a letter to Mills on Sunday calling for better communication between the governor's office and GOP legislators. The Republicans charged that they are learning of policy changes via Mills' news conference instead of being informed about them beforehand. They cited Mills' extension of Maine's “state of civil emergency," which she pushed to May 15 last week. The GOP members also wrote that they are concerned about what plans are being made to reopen business in Maine. “We know the department is very busy but also believe it is imperative that plans have begun to...
  • 04/20/2020

IDEXX Labs launches COVID-19 test for pets amid rare cases of human-to-pet transmission

  • IDEXX Laboratories Inc said on Monday it would provide veterinarians a COVID-19 test for pets amid evidence that infected humans could transmit the virus to their pets.
  • 04/20/2020

IDEXX Labs launches COVID-19 test for pets amid rare cases of human-to-pet transmission

  • IDEXX Laboratories Inc said on Monday it would provide veterinarians a COVID-19 test for pets amid evidence that infected humans could transmit the virus to their pets.The company advised that vete…
  • 04/20/2020

IDEXX Labs launches COVID-19 test for pets amid rare cases of human-to-pet transmission

  • IDEXX Laboratories Inc said on Monday it would provide veterinarians a COVID-19 test for pets amid evidence that infected humans could transmit the virus to their pets. The company advised that veterinarians order the test after consulting a public health authority and only if other common infections have been ruled out in pets showing symptoms and those that have been living in a household with an infected person. Earlier this month, researchers found that cats and ferrets could catch the coronavirus, prompting the World Health Organization to say it will take a closer look at transmission of the virus between humans and pets.
  • 04/20/2020

BRIEF-Idexx Makes Pet Test For COVID-19 Virus Available To Veterinarians

  • IDEXX Laboratories Inc:
  • 04/20/2020

IDEXX Makes Pet Test for COVID-19 Virus Available to Veterinarians

  • IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR™ Test for pets. IDEXX is launching the test in response to customer demand and growing evidence that in rare cases pets living with COVID-19 positive humans can be at risk for SARS-CoV-2 infection. The test will be available to veterinarians in North America this week and will continue to roll out across most of the world in the coming weeks, enabled by IDEXX Reference Laboratories, the company's worldwide network of more than 80 laboratories.
  • 04/20/2020

Top-Rated Stocks Near Buy Point With Earnings Due: Idexx Laboratories

  • 04/20/2020

Las mascotas son víctimas del coronavirus, pero no lo contagian

  • El 3 de marzo, los servicios sanitarios de Hong Kong realizaron pruebas a 27 perros y 15 gatos que guardaban cuarentena por haber convivido con humanos contagiados. Solamente dos perros y un gato dieron positivo a las pruebas del coronavirus
  • 04/18/2020

What Is IDEXX Laboratories's (NASDAQ:IDXX) P/E Ratio After Its Share Price Rocketed?

  • IDEXX Laboratories (NASDAQ:IDXX) shareholders are no doubt pleased to see that the share price has bounced 37% in the...
  • 04/18/2020

How Does IDEXX Laboratories’s (NASDAQ:IDXX) P/E Compare To Its Industry, After Its Big Share Price Gain?

  • Those holding IDEXX Laboratories (NASDAQ:IDXX) shares must be pleased that the share price has rebounded 37% in the...
  • 04/18/2020

Donaldson Capital Management LLC Grows Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

  • Donaldson Capital Management LLC increased its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 29.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,710 shares of the company’s stock after acquiring an additional 392 shares during the quarter. Donaldson Capital Management LLC’s holdings […]
  • 04/17/2020

BRIEF-IDEXX Laboratories Inc Enters Second Amendment To Note Purchase And Private Shelf Agreement

  • IDEXX Laboratories Inc:
  • 04/16/2020

Coronavirus Hits S&P 500: 4 MedTech Stocks That Fared Better

  • Here are a few MedTech companies which have outperformed the S&P 500 index in the past two months.
  • 04/03/2020

IDEXX's (IDXX) CAG Arm Grows Strong on Product Launches

  • Product launches like Cornerstone, Neo, Animana aid IDEXX' (IDXX) CAG business.
  • 04/03/2020

Is IDEXX Laboratories Stock a Buy?

  • What's the verdict on this animal healthcare company?
  • 03/14/2020

WHO Says There's No Evidence That Pets Can Pass Coronavirus to Humans

  • But now, the agency isn't so sure about whether people can transmit the disease to dogs and cats.
  • 03/13/2020

5 Must-Buy S&P 500 Large-Cap Growth Stocks at a Discount

  • As a result of regular market fluctuations, several growth stocks have become ultra-cheap at present, some of which have strong growth potential.
  • 03/05/2020

IDEXX Laboratories: A Widening Moat and a Massive Runway Ahead

  • “Dog is a man’s best friend.” This old saying has seen its business implications increasing these days.
  • 03/04/2020

Why Is Idexx (IDXX) Down 10.3% Since Last Earnings Report?

  • Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
  • 03/01/2020

Here's Why You Should Retain IDEXX Laboratories Stock Now

  • Investor confidence remains high in IDEXX (IDXX) stock, thanks to solid prospects.
  • 02/05/2020

IDEXX Laboratories, Inc. (IDXX) CEO Jonathan Mazelsky on Q4 2019 Results - Earnings Call Transcript

  • IDEXX Laboratories, Inc. (IDXX) CEO Jonathan Mazelsky on Q4 2019 Results - Earnings Call Transcript
  • 01/31/2020

How Idexx Laboratories Beat Expectations in Q4

  • The animal health company boosted its full-year 2020 earnings guidance, too.
  • 01/31/2020

IDEXX (IDXX) Q4 Earnings Top Estimates, Revenues Grow Y/Y

  • The year-over-year upside in IDEXX's (IDXX) revenues was primarily driven by strong global gains in CAG Diagnostics' recurring revenues.
  • 01/31/2020

Earnings Preview: Idexx Laboratories (IDXX) Q4 Earnings Expected to Decline

  • Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
  • 01/24/2020

What's in Store for IDEXX Laboratories' (IDXX) Q4 Earnings?

  • IDEXX's (IDXX) is likely to report strong earnings for Q4, courtesy of a global surge in CAG Diagnostic revenues.
  • 01/24/2020

The No-Brainer Industry You Should Be Investing In

  • Recession or not, spending in this industry increases every single year.
  • 01/24/2020

10 Recession-Resistant Services Stocks to Buy

  • Seemingly every day, the fundamentals surrounding the U.S. economy seem to deteriorate.
  • 01/22/2020

IDEXX Launches Cytology Service to Upgrade Veterinary Care

  • IDEXX (IDXX) upgrades veterinary care experience by launching a rapid digital cytology service, thus enabling the provision of faster results.
  • 01/20/2020

S&P 500 Up 1000 Points in a Month: 10 Stocks Boosted the ETF

  • The S&P 500 touched the 3,300 mark on Jan 16, having added 1000 points in less than a month. Which stocks led to the ETF rally.
  • 01/17/2020

Why IDEXX Laboratories Stock Dropped 12% in November

  • Investors needed to see more growth to justify the high valuation on the stock.
  • 12/04/2019

3 Big Stock Charts for Tuesday: Costco, IDEXX Laboratories, and Ulta Beauty

  • Tuesday's big stock charts look at 3 names that could reverse if market strength continues. The post 3 Big Stock Charts for Tuesday: Costco, IDEXX Laboratories, and Ulta Beauty appeared first on InvestorPlace.
  • 11/26/2019

You Love Your Dog More Than Humans -- And This Company's Reaping the Benefits

  • IDEXX Laboratories is salivating at a $33 billion global addressable market opportunity.
  • 11/21/2019

Top-Ranked Nasdaq-100 ETF at New High: 5 Best Stocks

  • Likelihood of a soon-to-be-signed U.S.-China trade deal, upbeat holiday season sales expectations and decent earnings have led the Nasdaq-100 ETF to a new high.
  • 11/13/2019

We Love Our Pets, and IDEXX Knows It

  • How the diagnostics company could be poised to profit from the companion animal industry.
  • 11/12/2019

IDEXX Laboratories, Inc.'s (IDXX) CEO Jay Mazelsky on Q3 2019 Results - Earnings Call Transcript

  • IDEXX Laboratories, Inc.'s (IDXX) CEO Jay Mazelsky on Q3 2019 Results - Earnings Call Transcript
  • 10/31/2019

IDEXX (IDXX) Tops Q3 Earnings Estimates, Lowers EPS View

  • IDEXX (IDXX) impresses investors with solid third-quarter 2019 results on robust performance across all business segments.
  • 10/31/2019

13 Stocks With The Highest Returns On Equity

  • Return on equity is one of the most popular ways for investors to assess the efficiency of a business before they buy a stock.
  • 10/31/2019

Medical Instruments' Oct 31 Earnings Roster: IDXX, ABMD & More

  • Earnings and revenues for the Medical Instruments sector in the third quarter are likely to have declined sequentially. Read to know how a few companies from the sector might have fared in the period.
  • 10/30/2019

What's in Store for IDEXX Laboratories' (IDXX) Q3 Earnings?

  • Growth in Rapid Assays and Veterinary Software revenues is expected to get reflected in IDEXX's (IDXX) third-quarter results.
  • 10/22/2019

Here's Why You Should Hold on to IDEXX (IDXX) Stock for Now

  • Investors continue to be optimistic about IDEXX's (IDXX) performance.
  • 10/16/2019

IDEXX's Kidney Function Test Included in IRIS Staging Views

  • IDEXX (IDXX) is upbeat about the inclusion and approval of the SDMA-based renal care staging guidelines.
  • 10/07/2019

3 Recession-Ready Stocks - to Buy Right Now

  • If you're looking for conservative stocks to cushion your portfolio against a downturn, look to companies whose offerings are hard to do without.
  • 10/04/2019

Two Leading Medical Stocks To Know As They Approach Buy Points

  • Shares of medical stocks Idexx Laboratories and Masimo approached breakouts Friday as Wall Street enjoyed a third day of gains. Both stocks are now in the process of forming flat bases.
  • 09/06/2019

Idexx (IDXX) Up 8% Since Last Earnings Report: Can It Continue?

  • Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
  • 08/31/2019

Here's Why You Should Hold Onto IDEXX (IDXX) Stock for Now

  • Investor confidence continues to be high on IDEXX Laboratories' (IDXX) prospects.
  • 08/20/2019

Idexx Laboratories Inc (IDXX) Interim President & CEO Jay Mazelsky Sold $2.6 million of Shares

  • Interim President & CEO of Idexx Laboratories Inc (30-Year Financial, Insider Trades) Jay Mazelsky (insider trades) sold 10,000 shares of IDXX on 08/05/2019 at an average price of $258.4 a share.
  • 08/07/2019

IDEXX Labs Fetches Double-Digit Profit Growth

  • The animal diagnostic company continues to turn single-digit revenue growth into big gains on the bottom line.
  • 08/03/2019

IDEXX Laboratories' (IDXX) Management on Q2 2019 Results - Earnings Call Transcript

  • IDEXX Laboratories' (IDXX) Management on Q2 2019 Results - Earnings Call Transcript
  • 08/01/2019

IDEXX (IDXX) Beats Q2 Earnings Estimates, Lifts EPS Guidance

  • IDEXX's (IDXX) top line in the second quarter gains from strong sales at the CAG business.
  • 08/01/2019

Idexx Laboratories (IDXX) Q2 Earnings Surpass Estimates

  • Idexx (IDXX) delivered earnings and revenue surprises of 4.38% and -1.25%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
  • 08/01/2019

Can IDEXX's (IDXX) International Growth Drive Q2 Earnings?

  • In the United States, IDEXX (IDXX) witnesses a strong uptrend in CAG Diagnostic recurring revenues.
  • 07/26/2019

Why the Earnings Surprise Streak Could Continue for Idexx (IDXX)

  • Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
  • 07/23/2019

2 Stocks to Play the Pet Care Trend

  • With consumers spending as much as $72 billion on their pets in 2018, here are 2 companies that could benefit most from our love of animals.
  • 06/24/2019

IDEXX (IDXX) Gains Traction From Solid CAG, Global Strength

  • IDEXX (IDXX) consistently benefits from strong organic growth, driven by robust sales at the CAG business, fueled by a firm global Catalyst adoption.
  • 06/21/2019

Why Is Idexx (IDXX) Up 3% Since Last Earnings Report?

  • Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
  • 05/31/2019

Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now

  • IDEXX (IDXX) registers strong revenue growth on the back of CAG Diagnostics.
  • 05/29/2019

Idexx Labs CEO: Millennials and Pet Care | Mad Money | CNBC

  • Idexx Laboratories CEO Jonathan Ayers chats with Jim Cramer about growing demand for preventative care for dogs and cats, and explains growth prospects for the veterinary diagnostics company.
  • 05/23/2019

Moving Average Crossover Alert: IDEXX Laboratories

  • IDEXX Laboratories is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
  • 05/06/2019

Rising Margins Allow IDEXX Laboratories to Boost Guidance

  • Expense control is helping the animal diagnostic company drive double-digit profit growth.
  • 05/01/2019

IDEXX Laboratories' (IDXX) CEO Jon Ayers on Q1 2019 Results - Earnings Call Transcript

  • IDEXX Laboratories' (IDXX) CEO Jon Ayers on Q1 2019 Results - Earnings Call Transcript
  • 05/01/2019

Idexx Laboratories (IDXX) Beats Q1 Earnings and Revenue Estimates

  • Idexx (IDXX) delivered earnings and revenue surprises of 12.50% and 0.83%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
  • 05/01/2019

IDEXX (IDXX) Q1 Earnings Top Estimates, EPS Guidance Up

  • Strong sales at the CAG business favor IDEXX's (IDXX) top line in Q1.
  • 05/01/2019

Can Steady CAG Growth Drive IDEXX's (IDXX) Q1 Earnings?

  • Idexx (IDXX) is expected to continue reporting solid revenue growth on robust CAG performance.
  • 04/30/2019

Idexx Laboratories CEO: Giving Pets a ‘Voice' | Mad Money | CNBC

  • It's the dog days of summer, but Jim Cramer's got one red-hot stock that may be worth owning. He sits down with the CEO of Idexx Labs to see if owning its stock could have you barking up the right tree. » Subscribe to CNBC:
  • 08/08/2018
Unlock
IDXX Ratings Summary
IDXX Quant Ranking